[{"text": "PREMIUM 89bio Launches $250 Million Securities Offering -- Shares Down After Hours MT Newswires Tue, Jan 28, 2025, 1:37 AM 89bio (ETNB) said late Monday it launched a public offering of $250 million in common shares or, in PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2025-01-27T22:37:05+00:00", "sentiment": {"score": 0.017660731449723244, "confidence": 0.044975683093070984, "probabilities": {"positive": 0.044975683093070984, "negative": 0.02731495164334774, "neutral": 0.9277094006538391}}, "embedding": [-0.05741269886493683, -0.11564437299966812, -0.03178704157471657, 0.09479138255119324, -0.0037079970352351665, 0.10782963782548904, -0.02212914638221264, 0.19828484952449799, 0.021309632807970047, 0.003394678235054016, 0.020163606852293015, -0.0012343362905085087, 0.09958627820014954, -0.04804205149412155, 0.052180591970682144, -0.0896296426653862, 0.03803086653351784, -0.17666837573051453, 0.007637198083102703, 0.09050262719392776, -0.147908553481102, 0.00851313304156065, -0.1790725141763687, -0.2189618945121765, 0.08774570375680923, -0.032299842685461044, 0.04971986636519432, -0.11941564083099365, -0.004747096914798021, 0.015392809174954891, 0.07246461510658264, -0.0645264983177185, 0.18428009748458862, 0.04835673049092293, -0.028675634413957596, -0.07279261946678162, -0.029967112466692924, 0.06934233009815216, 0.09232424199581146, -0.1609800010919571, 0.02234661765396595, -0.008152006193995476, -0.07298583537340164, 0.20759214460849762, 0.09259193390607834, -0.013794457539916039, 0.06473581492900848, 0.08231745660305023, 0.09900430589914322, 0.016541436314582825, 0.030837109312415123, -0.13283288478851318, -0.0019616624340415, 0.07222450524568558, 0.005212249234318733, -0.08783487230539322, -0.20266956090927124, -0.15251637995243073, 0.048778899013996124, -0.009851248934864998, 0.07804957777261734, -0.07459001988172531, 0.014711428433656693, 0.01315816305577755, -0.03191365301609039, -0.005186085589230061, 0.1938970983028412, 0.08823360502719879, -0.02014167234301567, -0.05911008268594742, 0.1484123170375824, 0.10452267527580261, -0.06412580609321594, 0.14220429956912994, -0.09066484868526459, 0.3309628665447235, 0.21498170495033264, -0.00484465854242444, -0.08184491842985153, -0.1223919540643692, -0.05208428204059601, -0.13138176500797272, 0.008135026320815086, -0.07705465704202652, -0.012242472730576992, -0.04816453903913498, -0.0009450462530367076, -0.06475747376680374, -0.008522981777787209, -0.046350717544555664, 0.16750718653202057, -0.06207438185811043, 0.11015573889017105, -0.05146009474992752, -0.11647789925336838, -0.06022417172789574, -0.29659411311149597, -0.09389861673116684, -0.05185180902481079, 0.051370587199926376, 0.0434492863714695, 0.17842639982700348, -0.19040550291538239, 0.002962939441204071, -0.16423240303993225, -0.10678413510322571, 0.10460782051086426, 0.19215145707130432, 0.008421054109930992, 0.08635814487934113, -0.15921808779239655, -0.0020977382082492113, -0.1440964788198471, -0.10180915147066116, -0.12778857350349426, 0.00889592058956623, -0.0952749103307724, 0.004887186922132969, 0.1694181263446808, -0.02466384693980217, -0.014957170933485031, 0.1416374146938324, -0.0596255287528038, -0.023871345445513725, -0.14197435975074768, 0.009773493744432926, -0.08482392877340317, 9.17563560008221e-33, -0.09086529165506363, -0.007685755845159292, -0.10202474892139435, -0.05034174025058746, -0.038327865302562714, 0.07352663576602936, 0.10313116014003754, -0.0755382850766182, -0.2977871298789978, 0.10481943190097809, -0.1933744251728058, 0.2605254352092743, -0.004338165745139122, 0.1713026911020279, -0.06439053267240524, -0.12031685560941696, 0.0039021384436637163, 0.04078805446624756, 0.18722692131996155, -0.00998829398304224, 0.007640562951564789, 0.03833482414484024, 0.08077478408813477, 0.010951589792966843, 0.10308755189180374, 0.12700363993644714, 0.21565483510494232, -0.07104180753231049, 0.14974483847618103, 0.07459724694490433, -0.16487322747707367, 0.08311069011688232, -0.12565630674362183, -0.10678509622812271, 0.06293756514787674, 0.07634356617927551, 0.08294689655303955, -0.009231066331267357, 0.04803196340799332, -0.08599980920553207, -0.0025982954539358616, 0.11466188728809357, -0.19550010561943054, -0.1819380819797516, -0.0368964821100235, 0.0932963415980339, -0.09610899537801743, -0.015358055010437965, 0.15663057565689087, -0.04011062532663345, -0.1056549921631813, 0.014233768917620182, -0.22913230955600739, 0.17188629508018494, -0.10866599529981613, -0.18632958829402924, -0.13540802896022797, 0.07812045514583588, 0.08347927778959274, -0.012431935407221317, 0.18143631517887115, 0.1261613517999649, 0.01799563132226467, 0.13885167241096497, -0.29568812251091003, 0.2874191701412201, -0.04957583174109459, -0.0831991583108902, -0.20557819306850433, 0.13870812952518463, 0.1224423199892044, -0.17335782945156097, 0.06760447472333908, -0.11513372510671616, -0.09857718646526337, -0.005608533509075642, -0.06654965877532959, -0.005356376059353352, 0.29063910245895386, 0.2319881170988083, 0.09998893737792969, -0.06071886047720909, 0.17340676486492157, 0.06477466225624084, 0.11987555772066116, 0.1512548178434372, -0.023170389235019684, 0.17103348672389984, -0.14462563395500183, 0.0264835674315691, 0.1942271590232849, 0.11981802433729172, -0.11402002722024918, 0.1679452359676361, -0.042145319283008575, -1.2748741697238562e-32, -0.06359456479549408, -0.008301040157675743, -0.09480143338441849, -0.1543792337179184, -0.18569453060626984, -0.004318231716752052, -0.08918927609920502, 0.16315147280693054, -0.06871843338012695, 0.04450807347893715, 0.01388371642678976, 0.05579365789890289, 0.06990457326173782, 0.020566271618008614, -0.030503077432513237, -0.20010130107402802, 0.04287497699260712, -0.08087650686502457, 0.08019309490919113, -0.02792752906680107, -0.09255286306142807, 0.08647806942462921, 0.16711480915546417, 0.15665557980537415, 0.17762121558189392, -0.04578297957777977, 0.09590545296669006, 0.3418407738208771, 0.04635251313447952, -0.038522835820913315, -0.17899124324321747, -0.013084596954286098, -0.15465344488620758, 0.17283333837985992, -0.16233991086483002, 0.032091282308101654, 0.17256227135658264, 0.032193854451179504, 0.11803454905748367, -0.019465288147330284, 0.09577517956495285, -0.08364710211753845, -0.0801345631480217, 0.05840176343917847, 0.05026032030582428, 0.13031795620918274, 0.03269151598215103, -0.12029468268156052, 0.19719062745571136, -0.04901724308729172, 0.05653052031993866, 0.0038410311099141836, 0.18784873187541962, 0.07275931537151337, -0.06448958814144135, 0.05840747803449631, -0.10636439919471741, 0.06594302505254745, 0.18088525533676147, -0.06106889247894287, 0.14944468438625336, 0.22239337861537933, -0.10102766007184982, -0.008991841226816177, -0.045446887612342834, 0.1309202015399933, 0.10927478969097137, -0.07891044020652771, -0.05926332622766495, -0.14852622151374817, 0.08906140923500061, -0.22217532992362976, -0.1675535887479782, -0.2431003451347351, -0.04567161947488785, 0.3067254424095154, -0.07942784577608109, -0.02883818931877613, 0.0236826129257679, 0.1414886713027954, -0.05473609268665314, 0.006079085171222687, 0.04579449072480202, 0.012082906439900398, 0.019427917897701263, -0.06071050465106964, 0.016062362119555473, 0.020539987832307816, -0.08506477624177933, 0.12609831988811493, -0.25954747200012207, -0.1706114411354065, 0.01927071437239647, 0.0022011275868862867, -0.03953290358185768, -1.0023588004060002e-07, 0.051870450377464294, -0.17906519770622253, 0.114206463098526, -0.07470563799142838, 0.01909983716905117, -0.11884626746177673, -0.06182515248656273, 0.09544344246387482, 0.008300511166453362, 0.13624246418476105, 0.08139161020517349, -0.08805584907531738, -0.10807807743549347, 0.12508335709571838, -0.08826947212219238, -0.08718273043632507, -0.0900002270936966, 0.10739597678184509, 0.05306598171591759, 0.03747274726629257, -0.04645552486181259, 0.09912104159593582, 0.3312625586986542, -0.057598572224378586, -0.039480987936258316, 0.014442631043493748, -0.0844126045703888, 0.0072424630634486675, 0.012920539826154709, -0.09597937762737274, -0.0325312465429306, 0.04487721621990204, -0.09626752883195877, -0.012805601581931114, -0.11170685291290283, -0.03473224118351936, 0.045221682637929916, 0.060066696256399155, -0.01710555888712406, 0.04773962125182152, -0.1213245764374733, -0.1675807684659958, -0.06303249299526215, 0.030389191582798958, 0.0366380549967289, 0.04089261591434479, -0.2742128074169159, -0.0076561858877539635, 0.01981208845973015, -0.3646983504295349, 0.10186965018510818, -2.3667629648116417e-05, -0.06538407504558563, 0.08719900250434875, -0.1254987120628357, -0.07101278752088547, -0.2199910581111908, -0.03646647185087204, -0.06840860843658447, 0.13160480558872223, -0.06000710278749466, -0.4207327663898468, -0.19854791462421417, -0.06876258552074432], "changes": {"1wk": 3.2222217983669705}}, {"text": "89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants 89bio, Inc. Tue, Jan 28, 2025, 12:12 AM 5 min read In This Article: ETNB -3.23% 89bio, Inc. SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (\u201c89bio\u201d) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that it has commenced an underwritten public offering of $250.0 million of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, 89bio is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $37.5 million of shares of its common stock at the public offering price, less the underwriting discounts and commissions. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the securities to be sold in the offering are being offered by 89bio. 89bio intends to use the net proceeds from this proposed offering to fund ongoing clinical activities and development of pegozafermin, manufacturing related costs and other general corporate purposes, including working capital and operating expenses. Goldman Sachs & Co. LLC, Leerink Partners and BofA Securities are acting as lead book-running managers and Cantor is acting as book-running manager for the proposed offering. An automatically effective shelf registration statement relating to these securities was filed with the Securities and Exchange Commission (\u201cSEC\u201d) on May 23, 2023. The offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of an effective registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC\u2019s website, located at www.sec.gov. Prospective investors should read the preliminary prospectus supplement and the accompanying prospectus and other documents 89bio has filed with the SEC for more complete information about 89bio and the offering. Electronic copies of the preliminary prospectus supplement and the accompanying prospectus related to the offering may also be obtained by contacting Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526 or by email at prospectus-ny@ny.email.gs.com; Leerink Partners, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at (800) 808-7525, ext. 6105, or by email at syndicate@leerink.com ; BofA Securities, Attention: Prospectus Department, NC1-022-02-25, 201 North Tryon, Charlotte, NC 28255-0001, or by email at dg.prospectus_requests@bofa.com ; or Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at prospectus@cantor.com. Continua a leggere This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on advancing its lead candidate, pegozafermin, through Phase 3 clinical development for the treatment of metabolic dysfunction-associated steatohepatitis and severe hypertriglyceridemia. Pegozafermin is a specifically engineered fibroblast growth factor 21 analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco. Forward-Looking Statements Certain statements in this press release may constitute \u201cforward-looking statements\u201d within the meaning of the federal securities laws, including, but not limited to, 89bio\u2019s expectations regarding the progress of its clinical trials, the proposed offering, including the timing, size, structure and completion of the proposed offering on the anticipated terms, the anticipated use of the net proceeds of the offering and the grant to the underwriters of the option to purchase additional shares. Words such as \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cobjective,\u201d \u201cintend,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201ccan,\u201d \u201cwould,\u201d \u201cexpect,\u201d \u201cbelieve,\u201d \u201cdesign,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cpotential,\u201d \u201canticipate,\u201d \u201cgoal,\u201d \u201copportunity,\u201d \u201cdevelop,\u201d \u201cplan\u201d or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements. While 89bio believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in 89bio\u2019s filings with the SEC), many of which are beyond 89bio\u2019s control and subject to change. Actual results could be materially different. Risks and uncertainties include: changes as a result of market conditions or for other reasons; the risk that the offering will not be consummated; the impact of general economic, health, industrial or political conditions in the United States or internationally; and other risks and uncertainties identified in 89bio\u2019s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and other subsequent disclosure documents filed with the SEC. 89bio claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. 89bio expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. Investor Contact: Annie Chang 89bio, Inc. annie.chang@89bio.com PJ Kelleher LifeSci Advisors, LLC +1 617-430-7579 pkelleher@lifesciadvisors.com Media Contact: Sheryl Seapy Real Chemistry sseapy@realchemistry.com Visualizza commenti Condizioni e Informativa sulla privacy Privacy Dashboard Storie consigliate", "symbol": "ETNB", "date": "2025-01-27T21:12:00+00:00", "sentiment": {"score": 0.0014320239424705505, "confidence": 0.022523250430822372, "probabilities": {"positive": 0.022523250430822372, "negative": 0.021091226488351822, "neutral": 0.9563854336738586}}, "embedding": [-0.11538826674222946, -0.067635178565979, -0.04619407653808594, 0.009896017611026764, -0.07238718122243881, 0.08039503544569016, 0.034162044525146484, 0.24078574776649475, 0.12538127601146698, -0.0013653924688696861, 0.016153067350387573, 0.009051037952303886, 0.033296070992946625, -0.062057461589574814, -0.01195848360657692, -0.13434235751628876, 0.014031058177351952, -0.045694656670093536, -0.1252341866493225, 0.15224584937095642, -0.010553181171417236, 0.017639225348830223, -0.04954545199871063, -0.046491410583257675, -0.062140874564647675, -0.0731332004070282, 0.04391152784228325, -0.027372196316719055, -0.14572182297706604, -0.06196194887161255, 0.13649582862854004, 0.11715590208768845, 0.14026185870170593, -0.05895979329943657, 0.0427963063120842, -0.03933100402355194, -0.11271679401397705, 0.07291189581155777, 0.02471010759472847, -0.0009260550141334534, -0.05226678401231766, -0.03799324482679367, -0.0818510577082634, 0.16715803742408752, 0.08131764829158783, -0.07873532176017761, -0.04621794819831848, 0.09955978393554688, 0.03561454638838768, 0.06182205677032471, -0.13129521906375885, -0.13238012790679932, -0.009336027316749096, 0.09515118598937988, -0.03450796753168106, -0.05854371190071106, -0.1880609095096588, -0.13196316361427307, 0.022183585911989212, -0.012711060233414173, 0.08967484533786774, -0.004055708646774292, -0.002813352271914482, 0.0038862377405166626, 0.0919988825917244, 0.016987953335046768, 0.11025731265544891, -0.019983753561973572, 0.020228587090969086, 0.030849402770400047, 0.20360887050628662, -0.03232654929161072, -0.10133811831474304, 0.14229866862297058, -0.15456518530845642, 0.1300702840089798, 0.07608639448881149, 0.08003279566764832, 0.08766230195760727, -0.18069782853126526, -0.00179201178252697, 0.03594832867383957, 0.023830462247133255, -0.09584897011518478, -0.045853376388549805, -0.007669844664633274, -0.0006431709043681622, 0.13566254079341888, 0.06199714541435242, 0.013105133548378944, 0.1006125807762146, -0.06865076720714569, 0.018860366195440292, -0.11451134830713272, -0.037307366728782654, -0.05469287186861038, -0.11857171356678009, 0.027120467275381088, 0.04301813989877701, 0.09523177146911621, 0.060625799000263214, 0.048633817583322525, -0.09369371086359024, -0.030398372560739517, -0.11002416908740997, -0.10128892213106155, 0.054878346621990204, 0.007220815401524305, 0.022157995030283928, 0.059336356818675995, -0.14452919363975525, 0.050923168659210205, -0.09399138391017914, -0.04574938118457794, -0.10842898488044739, 0.10937270522117615, 0.043299250304698944, 0.008986454457044601, 0.15517160296440125, -0.040183790028095245, 0.08418911695480347, 0.10850335657596588, 0.0465402752161026, -0.1284981667995453, -0.10226676613092422, -0.08895380795001984, -0.08339229226112366, 7.141242791944602e-33, -0.08571731299161911, -0.08595098555088043, -0.02070833370089531, -0.027755117043852806, -0.010877180844545364, 0.03434748947620392, 0.040057115256786346, 0.013545816764235497, -0.1674070954322815, 0.05698273703455925, -0.13709130883216858, 0.10822997987270355, -0.01343708299100399, 0.07405520975589752, -0.07535833865404129, -0.04590967297554016, -0.011347624473273754, 0.09156157821416855, 0.12073457986116409, -0.019194411113858223, 0.04385364055633545, 0.04122397303581238, -0.008513707667589188, 0.04942936450242996, 0.023912891745567322, 0.044563617557287216, -0.022708168253302574, -0.00680742459371686, 0.011820949614048004, 0.02865421585738659, 0.0012316699139773846, 0.015239905565977097, -0.06431794166564941, -0.14323081076145172, -0.0006190033163875341, -0.05739748105406761, -0.0400359220802784, -0.0855020135641098, 0.08450347930192947, 0.04896081984043121, 0.012323644012212753, 0.09736500680446625, -0.07009110599756241, -0.08034320920705795, 0.02404162473976612, 0.029526222497224808, -0.07028608024120331, 0.08281213045120239, 0.0582469180226326, 0.03245674818754196, -0.054313041269779205, -0.030912548303604126, -0.046923138201236725, -0.04588865861296654, -0.04919770732522011, -0.06248990073800087, -0.17957405745983124, 0.012904033996164799, 0.029582485556602478, 0.08826075494289398, 0.1242290660738945, 0.15540266036987305, -0.10747828334569931, 0.09407944232225418, -0.25147730112075806, 0.0980781614780426, -0.0331171452999115, -0.026639513671398163, -0.06396758556365967, 0.04335305467247963, -0.03373591974377632, -0.09535256028175354, 0.0589764304459095, -0.0682443231344223, -0.04372350126504898, -0.05365176871418953, 0.002381450729444623, 0.08306121081113815, 0.05571441724896431, 0.03636518120765686, -0.041590429842472076, -0.013446744531393051, 0.01530184131115675, 0.13974016904830933, 0.006750272586941719, 0.049130961298942566, 0.011149505153298378, 0.030695229768753052, -0.08273442089557648, -0.024814054369926453, 0.10289042443037033, 0.05153967812657356, -0.12535005807876587, 0.15738660097122192, 0.06519953161478043, -7.599841341766778e-33, -0.027273407205939293, -0.09980767220258713, -0.04173313081264496, -0.06479130685329437, -0.04190954938530922, 0.11141732335090637, 0.03892466053366661, -0.12378982454538345, 0.023533258587121964, -0.14472772181034088, -0.08902496099472046, 0.03655602037906647, 0.029641784727573395, -0.07486718147993088, -0.05869542062282562, -0.0331556536257267, -0.042166564613580704, 0.03956160694360733, 0.0017279963940382004, 0.024228041991591454, -0.0418449342250824, 0.17399083077907562, 0.043061405420303345, -0.005156496539711952, 0.054394450038671494, 0.05513184517621994, 0.0780610591173172, 0.1898210048675537, -0.026457132771611214, 0.0661870688199997, -0.062232278287410736, -0.056151989847421646, -0.21570661664009094, 0.09686911851167679, -0.14800897240638733, -0.04874841496348381, 0.11793378740549088, -0.0549817755818367, 0.07985612750053406, 0.031229792162775993, 0.08831696212291718, 0.03462657332420349, 0.054523516446352005, 0.054122425615787506, 0.005479399114847183, -0.048186782747507095, 0.08435432612895966, -0.12106245011091232, 0.16532045602798462, 0.022426247596740723, 0.043392933905124664, -0.025903992354869843, 0.057019300758838654, 0.06296013295650482, -0.09763814508914948, 0.04952281340956688, -0.030211810022592545, -0.05685058608651161, 0.10191777348518372, 0.0035778293386101723, 0.10223270952701569, 0.19590693712234497, 0.05784571170806885, 0.0152704156935215, 0.15773151814937592, 0.020822299644351006, 0.04010526090860367, -0.007891839370131493, -0.0024438509717583656, -0.1398090273141861, -0.010415306314826012, -0.2152252197265625, -0.04203478991985321, -0.12037479877471924, -0.007259363308548927, 0.182688370347023, 0.009985089302062988, -0.114072784781456, -0.037517767399549484, 0.02385699935257435, -0.017396099865436554, 0.016126960515975952, -0.028325021266937256, 0.12526550889015198, -0.007375794462859631, -0.005227530840784311, 0.026151664555072784, 0.045742180198431015, -0.00337145384401083, 0.10450746864080429, -0.07372280955314636, -0.05079023912549019, 0.043748170137405396, 0.05816787853837013, -0.04185081645846367, -1.003249394671002e-07, 0.039342038333415985, -0.0996713936328888, 0.04093519225716591, -0.08847752958536148, 0.12016788125038147, -0.1044638454914093, -0.0013602925464510918, -0.050586484372615814, 0.02732132002711296, 0.08420567959547043, 0.13829869031906128, 0.1335310935974121, -0.1635884940624237, 0.03365716338157654, -0.1116226464509964, -0.035260770469903946, -0.09290896356105804, 0.05660196393728256, -0.11316835880279541, -0.002652393188327551, -0.07739517092704773, 0.06528793275356293, 0.10160612314939499, -0.06132105737924576, 0.02271525375545025, -0.06698369234800339, 0.01441940851509571, 0.0681956484913826, -0.0018191741546615958, 0.0647638738155365, -0.008418482728302479, 0.026012888178229332, 0.06970494985580444, 0.01664053276181221, -0.0304883923381567, -0.07741613686084747, 0.020486779510974884, 0.097511425614357, 0.003906500060111284, 0.06200260668992996, -0.08621179312467575, -0.09248730540275574, -0.05158451944589615, 0.037976160645484924, 0.11498567461967468, -0.0831574946641922, -0.20725208520889282, 0.04137660935521126, 0.0167199969291687, -0.1836676001548767, 0.014813853427767754, 0.010244946926832199, -0.003862882498651743, 0.06705714762210846, -0.11709152162075043, 0.10446229577064514, -0.09728413820266724, 0.01424260251224041, 0.0068395198322832584, -0.0003017690032720566, 0.03579649701714516, -0.21332895755767822, 0.04513672739267349, 0.0014199558645486832], "changes": {"1wk": 3.2222217983669705}}, {"text": "Akero Therapeutics Stock Nearly Doubles \u2014 Pulling 89bio Higher \u2014 On Positive MASH Study Akero Therapeutics Stock Nearly Doubles \u2014 Pulling 89bio Higher \u2014 On Positive MASH Study \u00b7 Investor's Business Daily ALLISON GATLIN Tue, Jan 28, 2025, 12:24 AM 2 min read In This Article: AKRO -0.43% ETNB -3.23% Akero Therapeutics nearly doubled Monday \u2014 and pulled 89bio shares higher \u2014 after the company's treatment for MASH obliterated expectations. Continue Reading View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2025-01-27T21:24:11+00:00", "sentiment": {"score": 0.4870246611535549, "confidence": 0.531916081905365, "probabilities": {"positive": 0.531916081905365, "negative": 0.044891420751810074, "neutral": 0.4231925308704376}}, "embedding": [-0.0404059961438179, -0.10100596398115158, 0.002602103166282177, 0.13301219046115875, -0.15550300478935242, 0.054005980491638184, 0.01858191005885601, 0.22303743660449982, 0.0037934184074401855, -0.03275981545448303, -0.047950685024261475, 0.10196525603532791, -0.09884060174226761, -0.02719157375395298, 0.04956201836466789, -0.17268849909305573, 0.03236714005470276, 0.023481978103518486, -0.0806969404220581, -0.01707538776099682, -0.20654262602329254, -0.20172171294689178, 0.04175569489598274, 0.0278038140386343, 0.1831136792898178, -0.025177564471960068, -0.07497277855873108, 0.09389332681894302, -0.03316526114940643, -0.2003915160894394, -0.06976489722728729, 0.09711328893899918, 0.21088215708732605, 0.006644935347139835, -0.172078475356102, -0.02513769641518593, -0.14341582357883453, 0.1450808197259903, 0.0739210993051529, -0.1047181487083435, 0.0959676131606102, -0.1373702585697174, 0.0351540744304657, -0.02273554727435112, -0.036899782717227936, -0.19492770731449127, -0.0986672192811966, -0.07397246360778809, 0.19208447635173798, 0.16065841913223267, -0.25968536734580994, -0.17310987412929535, 0.18773865699768066, 0.07720838487148285, 0.14394882321357727, -0.06431232392787933, -0.23953314125537872, -0.06141231581568718, 0.007222144398838282, 0.08381230384111404, 0.1483708769083023, 0.06524457037448883, 0.02842053398489952, -0.021096058189868927, 0.1380489468574524, -0.0030449547339230776, 0.09887845814228058, -0.019542565569281578, -0.020493969321250916, 0.0519990473985672, 0.31780698895454407, 0.009619923308491707, 0.024891313165426254, 0.11529440432786942, -0.13097698986530304, 0.1592983603477478, -0.036859311163425446, 0.06090787798166275, 0.1005655899643898, -0.02713886834681034, 0.07626258581876755, -0.03468986600637436, -0.003447226481512189, -0.12627016007900238, -0.05935351178050041, -0.07269708812236786, 0.08320792019367218, -0.030253851786255836, -0.00872038397938013, 0.1064915880560875, 0.24789367616176605, 0.0767524242401123, 0.1503545492887497, -0.08784005045890808, -0.039593905210494995, -0.06205684691667557, -0.3416306674480438, 0.026786653324961662, -0.09758641570806503, 0.054888103157281876, 0.0798867791891098, 0.36508995294570923, -0.19810393452644348, 0.054136522114276886, -0.08922592550516129, -0.1743222177028656, 0.0077095734886825085, 0.0035112572368234396, -0.0940401703119278, 0.0713374987244606, -0.020549612119793892, 0.15490372478961945, -0.07172591984272003, 0.009873691946268082, -0.085502490401268, 0.1380179524421692, 0.07868427783250809, 0.08203678578138351, 0.02824288047850132, 0.10890775173902512, -0.07014916837215424, 0.06588480621576309, -0.018793556839227676, -0.04645395651459694, -0.011247707530856133, 0.03046003170311451, -0.09398534148931503, 1.5528133437568565e-32, -0.020012851804494858, -0.01725286804139614, 0.041752442717552185, 0.01648743636906147, 0.008045160211622715, -0.12015534937381744, -0.19893145561218262, -0.08081787824630737, -0.19638371467590332, -0.14491641521453857, -0.17858149111270905, 0.12476716935634613, 0.0494668185710907, 0.1386207938194275, -0.15910929441452026, -0.12849417328834534, -0.013756421394646168, 0.014082263223826885, 0.1805611550807953, -0.04282316938042641, -0.0015693651512265205, -0.013198143802583218, -0.05942704901099205, 0.09221766889095306, 0.032765936106443405, -0.02193855307996273, -0.051882121711969376, -0.005631173495203257, -0.02352709323167801, 0.055880267173051834, -0.024054208770394325, 0.07816556096076965, -0.06173831596970558, -0.04054722562432289, -0.1690896898508072, -0.010315956547856331, -0.024489806964993477, 0.016850152984261513, 0.024423735216259956, 0.041785817593336105, -0.10032275319099426, 0.1458970010280609, -0.035971399396657944, -0.14584973454475403, -0.0023615495301783085, 0.0002742637589108199, -0.23002609610557556, -0.046565670520067215, 0.1502176821231842, 0.0976458340883255, -0.10862697660923004, 0.03271209076046944, -0.04969307407736778, 0.05922526493668556, -0.032385554164648056, -0.09273212403059006, -0.16428428888320923, -0.026395278051495552, 0.08717266470193863, 0.1755710244178772, 0.20455999672412872, 0.13499487936496735, 0.039168983697891235, 0.06735480576753616, -0.31285861134529114, 0.1550133377313614, -0.06166527047753334, -0.10425461828708649, -0.15866971015930176, 0.27115410566329956, 0.03941446915268898, 0.0032785136718302965, 0.11295218765735626, -0.05434303730726242, -0.043703675270080566, -0.07843711227178574, -0.008854170329868793, -0.010914786718785763, 0.1303015500307083, 0.1691199690103531, 0.06321528553962708, -0.11897750943899155, 0.07194790244102478, 0.18260209262371063, -0.031198415905237198, 0.16131794452667236, -0.04153335839509964, 0.03286799043416977, -0.14859455823898315, 0.11074744910001755, 0.1600143313407898, 0.09084223955869675, -0.1052800789475441, 0.12330836057662964, 0.01458973903208971, -1.6726085607963313e-32, 0.1790846288204193, 0.07715582102537155, -0.0034280898980796337, -0.1681659072637558, -0.11965329200029373, 0.12129749357700348, 0.04563906788825989, -0.029379723593592644, -0.05497267097234726, 0.08165787160396576, 0.2513483762741089, 0.08748157322406769, 0.08716518431901932, -0.043319057673215866, -0.07048019021749496, -0.2686777710914612, 0.17456525564193726, 0.013722008094191551, 0.017865605652332306, -0.06811332702636719, -0.06973496079444885, 0.18937447667121887, 0.09804890304803848, 0.17926418781280518, 0.1691640168428421, 0.03674811124801636, 0.030973143875598907, 0.23939837515354156, -0.08045829087495804, -0.05041017383337021, 0.06958138197660446, -0.09545120596885681, -0.2898562252521515, 0.05996597930788994, -0.06737887114286423, 0.017617423087358475, 0.1081518605351448, -0.040624842047691345, 0.0310855470597744, -0.07861381769180298, 0.019794389605522156, 0.118707574903965, -0.10752873867750168, 0.12103061378002167, 0.08195076882839203, 0.07730714976787567, 0.13838990032672882, -0.07334861904382706, 0.2745824158191681, -0.16635309159755707, 0.04946783557534218, -0.031216273084282875, -0.01677895337343216, 0.0637589618563652, -0.014914406463503838, 0.014888131059706211, -0.04271736368536949, -0.11202843487262726, -0.1670045107603073, 0.05085812881588936, -0.030399426817893982, 0.09732737392187119, -0.1488470435142517, -0.06588908284902573, -0.1798783838748932, 0.07513998448848724, 0.06638870388269424, -0.05720696225762367, 0.06535777449607849, -0.14238780736923218, 0.10787680000066757, -0.12886525690555573, 0.046217478811740875, 0.022581616416573524, -0.04060574620962143, 0.2791565954685211, -0.07178895175457001, -0.04658801853656769, -0.0336308516561985, 0.010527853854000568, 0.05860515311360359, -0.09608256071805954, -0.08069115877151489, 0.08869002759456635, -0.13191676139831543, 0.04852589592337608, 0.07614391297101974, -0.01622854173183441, 0.0433180145919323, 0.10211241245269775, -0.16788773238658905, -0.15372875332832336, -0.180099755525589, -0.05095204338431358, 0.0017439555376768112, -1.0074218437239324e-07, 0.16600802540779114, -0.3738526403903961, 0.10611660778522491, 0.03205826133489609, 0.007509233430027962, -0.018810778856277466, -0.06352221220731735, -0.034904345870018005, -0.030426090583205223, 0.16062377393245697, -0.1254161149263382, 0.16003356873989105, -0.2118019461631775, -0.02425655536353588, -0.009290609508752823, -0.166703462600708, -0.012846089899539948, 0.13789179921150208, -0.025753067806363106, -0.10703910142183304, -0.14708569645881653, 0.04328925162553787, 0.23123683035373688, -0.04863866791129112, -0.05351212993264198, 0.15021160244941711, -0.003290365682914853, 0.021490011364221573, -0.030063705518841743, -0.04325937107205391, 0.10634839534759521, -0.09563696384429932, 0.11076512187719345, -0.01444263942539692, -0.02413412742316723, -0.16071876883506775, 0.09786275029182434, 0.05120022967457771, -0.01819557324051857, -0.09672660380601883, -0.14922747015953064, -0.19464696943759918, -0.0623641200363636, 0.1102709248661995, -0.13558970391750336, 0.01948154717683792, -0.18829475343227386, 0.04346071556210518, -0.006454594898968935, -0.2907435894012451, 0.24405483901500702, -0.015256674028933048, 0.05436927080154419, 0.1613183319568634, -0.09846097975969315, 0.10055606812238693, -0.17828021943569183, -0.0619063638150692, -0.11824973672628403, -0.006463920697569847, 0.07814411073923111, -0.30906087160110474, -0.11628028750419617, 0.008315651677548885], "changes": {"1wk": 3.2222217983669705}}, {"text": "Akero's Stock Skyrockets 112% After Game-Changing Liver Drug Data Khac Phu Nguyen Mon, Jan 27, 2025, 8:13 PM 1 min read In This Article: AKRO -0.43% Akero Therapeutics ( NASDAQ:AKRO ) just flipped the script on the MASH treatment market. Shares surged 112% this morning after jaw-dropping Phase 2b data showed its drug, efruxifermin (EFX), could actually reverse cirrhosisa condition long believed to be irreversible. The breakthrough crushed fears that Eli Lilly and Novo Nordisk's GLP-1 drugs would dominate the space, reigniting confidence in targeted therapies. With 39% of patients in the trial showing fibrosis reversalmore than double the placebo groupthe data isn't just good, it's game-changing. Jefferies wasted no time reaffirming its Buy rating with a $50 price target, while some analysts think Akero could hit $75 if Phase 3 trials confirm the results. Warning! GuruFocus has detected 3 Warning Signs with AKRO. This changes everything. Jefferies now sees a 75% probability of Phase 3 success, making Akero a prime takeover target as its market cap lags at $3.62 billion despite its potential. Investors took notice, sending shares of competitor 89bio ( NASDAQ:ETNB ) soaring 51% on the news. Citi also jumped in with a fresh Buy rating, pointing to EFX's potential to shake up the standard of care. If Akero keeps this momentum, it could soon be playing in the big leagues with valuations soaring toward $8 billion. Wall Street is locked in on what's next, and the stakes couldn't be higher. Meanwhile, not every biotech is celebrating. Keros Therapeutics just hit a roadblock, pausing parts of its Phase 2 TROPOS trial due to unexpected safety concerns. Biotech stocks are a rollercoaster, but Akero's stunning data is proof that when a breakthrough happens, the upside can be massive. With Phase 3 trials on deck, the market is watchingif Akero delivers again, this stock could be nowhere near its ceiling. This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2025-01-27T17:13:34+00:00", "sentiment": {"score": 0.6397738829255104, "confidence": 0.6999486088752747, "probabilities": {"positive": 0.6999486088752747, "negative": 0.06017472594976425, "neutral": 0.23987668752670288}}, "embedding": [-0.025120146572589874, -0.14128254354000092, -0.03463878110051155, 0.0014623263850808144, 0.06052108854055405, 0.006468034349381924, 0.036342669278383255, 0.2078191041946411, 0.11172997206449509, 0.12860581278800964, -0.07700087130069733, 0.08495595306158066, -0.06519416719675064, -0.0680280476808548, 0.006298233289271593, -0.07324602454900742, 0.05743258818984032, -0.05605240911245346, -0.12687930464744568, 0.08275899291038513, -0.07496766746044159, -0.09921719878911972, 0.011958882212638855, 0.0132157476618886, 0.03303820267319679, 0.0942748561501503, -0.04894918203353882, 0.013739105314016342, -0.13273170590400696, -0.17855983972549438, 0.009431631304323673, 0.09950220584869385, 0.08630766719579697, -0.06067080795764923, -0.06340107321739197, -0.04517210274934769, -0.1332625299692154, 0.042406242340803146, 0.01875101774930954, -0.057472337037324905, 0.09654231369495392, -0.09412547945976257, -0.20274773240089417, 0.020468229427933693, 0.051428571343421936, -0.177254319190979, -0.07696230709552765, -0.0032392193097621202, 0.0961003229022026, 0.05464322492480278, -0.19526706635951996, -0.216708242893219, 0.11725492030382156, -0.0069145094603300095, 0.013873190619051456, -0.05093570053577423, -0.09482403844594955, -0.06883782893419266, 0.06402887403964996, 0.08241517841815948, 0.05041007325053215, -0.04164635390043259, 0.013857639394700527, -0.015583816915750504, 0.14713340997695923, 0.016995619982481003, 0.0811070054769516, -0.05552138388156891, 0.014867274090647697, 0.08936160802841187, 0.11871089786291122, 0.01624518260359764, -0.0024462020955979824, 0.025284698233008385, 0.059566374868154526, 0.16206756234169006, 0.01271799672394991, 0.040601104497909546, 0.10168424248695374, -0.0007772475364618003, 0.0963793694972992, -0.010364356450736523, 0.05041588097810745, -0.1563217043876648, -0.01782497763633728, -0.05592508986592293, 0.0071336994878947735, 0.014368767850100994, 0.08547426015138626, -0.03959329053759575, 0.10227329283952713, 0.033985529094934464, 0.08233951032161713, -0.011559469625353813, 0.07757827639579773, 0.03197619691491127, -0.15086893737316132, 0.012148064561188221, -0.01765277236700058, 0.0501289926469326, 0.04710701107978821, 0.17824018001556396, -0.132376030087471, -0.036420125514268875, -0.045691508799791336, -0.11416841298341751, 0.06534899026155472, -0.015495655126869678, -0.0453062541782856, 0.04776572063565254, -0.1449144184589386, 0.053318072110414505, -0.0065064579248428345, -0.013054716400802135, -0.06460017710924149, 0.1263585090637207, -0.009293654933571815, -0.03467140346765518, 0.11444201320409775, 0.02694864384829998, 0.031338661909103394, -0.006107024382799864, -0.0026202211156487465, -0.03869715332984924, 0.04162953794002533, 0.08213124424219131, -0.16782666742801666, 1.3664979299619055e-32, 0.045497894287109375, 0.0963139608502388, 0.005811790935695171, -0.08546385914087296, -0.053694043308496475, -0.004442705772817135, -0.08825914561748505, -0.08057897537946701, -0.09802936762571335, -0.06487441062927246, -0.14503413438796997, 0.0784427747130394, -0.0503302738070488, 0.06489159911870956, 0.010889324359595776, -0.11719778925180435, -0.040237907320261, 0.05110868439078331, 0.02147168479859829, -0.036394476890563965, 0.04092904180288315, -0.024186234921216965, -0.12308923900127411, -0.012902184389531612, -0.07530830800533295, 0.07688872516155243, -0.0735064148902893, 0.018179727718234062, -0.0009192869765684009, 0.048382747918367386, -0.13121844828128815, 0.07641629874706268, 0.004540081601589918, 0.05014832317829132, -0.14439913630485535, -0.08640732616186142, -0.12138617038726807, -0.10692643374204636, 0.0013245193986222148, 0.0764121562242508, -0.10462573915719986, 0.13474012911319733, -0.11863019317388535, -0.05235503613948822, 0.000932548486161977, -0.061097946017980576, -0.13709643483161926, -0.04374516382813454, -0.08168680220842361, -0.0019750811625272036, 0.01594593934714794, 0.08609281480312347, 0.027566619217395782, 0.03566575050354004, -0.022302502766251564, 0.008562905713915825, -0.10690888017416, -0.1202443540096283, 0.021176191046833992, 0.12233441323041916, 0.14045575261116028, 0.05784517154097557, 0.01854115165770054, 0.08560285717248917, -0.17607231438159943, 0.16957645118236542, -0.0625189021229744, -0.020551208406686783, -0.18135401606559753, 0.19070705771446228, 0.009798591956496239, 0.025277629494667053, 0.04690837487578392, -0.004860795568674803, -0.018809307366609573, -0.12005188316106796, -0.019338363781571388, 0.09004277735948563, -0.02912367507815361, 0.03393879160284996, 0.06938191503286362, -0.07989050447940826, -0.008758955635130405, 0.07352501153945923, -0.03848286345601082, -0.06642428785562515, 0.0026937746442854404, 0.017186591401696205, -0.1503669023513794, -0.0322820283472538, 0.05116954445838928, -0.04093090817332268, -0.01750585250556469, 0.1650800108909607, 0.053392451256513596, -1.3465715374739415e-32, 0.040962476283311844, -0.030531132593750954, 0.026669306680560112, -0.05610679090023041, -0.049844421446323395, 0.10234793275594711, 0.13961681723594666, -0.07359214127063751, 0.07378088682889938, 0.005540354177355766, 0.04624753072857857, 0.080879807472229, 0.051653385162353516, -0.06573666632175446, -0.048302311450242996, -0.1399611383676529, 0.11782050877809525, -0.06590083986520767, 0.00561364134773612, -0.076463483273983, 0.04859338328242302, 0.1084660217165947, -0.1259400099515915, 0.14584888517856598, -0.03679049015045166, 0.05095658078789711, 0.06939651817083359, 0.0668708086013794, -0.07476973533630371, -0.045235928148031235, -0.033985115587711334, 0.00026883193640969694, -0.17102983593940735, 0.11304829269647598, -0.007737377192825079, 0.0863974466919899, 0.00454688398167491, -0.1242862269282341, -0.0740603655576706, -0.024511946365237236, 0.06470908224582672, 0.09121986478567123, -0.0721377283334732, 0.005173862911760807, 0.04470112547278404, 0.0306528452783823, 0.11467447131872177, -0.02368905022740364, 0.23335543274879456, -0.08344662934541702, 0.02557273954153061, 0.09225577116012573, 0.018576107919216156, 0.10103786736726761, -0.06555147469043732, 0.014953735284507275, 0.003554755123332143, -0.043955717235803604, -0.10434355586767197, 0.06761106848716736, -0.02962370775640011, 0.09405507892370224, -0.00031776182004250586, -0.08312675356864929, 0.024528825655579567, 0.04572826251387596, 0.047438014298677444, -0.0363580584526062, 0.0625234991312027, -0.06045539304614067, 0.03010823018848896, -0.014510286040604115, -0.041678257286548615, 0.02241341397166252, -0.0013803679030388594, 0.22305302321910858, -0.08206906914710999, -0.035982646048069, -0.08021692931652069, -0.057517215609550476, 0.04839295893907547, -0.0998840257525444, -0.023031556978821754, 0.04174969717860222, 0.023035753518342972, 0.07604440301656723, 0.027772914618253708, -0.035180117934942245, -0.07516101002693176, -0.018153546378016472, -0.008078519254922867, -0.17682838439941406, -0.1261235624551773, 0.13788039982318878, -0.017713818699121475, -1.0066727185176205e-07, 0.12230761349201202, -0.10080951452255249, 0.04369862377643585, 0.0032500012312084436, 0.0802617147564888, -0.012122425250709057, -0.017911503091454506, -0.013679240830242634, 0.025695741176605225, 0.15746141970157623, 0.06258055567741394, 0.17555230855941772, -0.10316754877567291, 0.007757733575999737, -0.01430258434265852, 0.027288494631648064, -0.12839636206626892, 0.04800873249769211, -0.007569351699203253, 0.015351825393736362, -0.14920835196971893, -0.008055398240685463, -0.012749156914651394, -0.08026932924985886, 0.06254564970731735, 0.002421286655589938, 0.05157254636287689, 0.08646062016487122, 0.06472323834896088, 0.08407622575759888, 0.014986086636781693, -0.15111157298088074, 0.08359832316637039, 0.07603123039007187, -0.043426934629678726, -0.05062408372759819, 0.11632586270570755, 0.09327781200408936, -0.009663194417953491, 0.047215718775987625, 0.01595417782664299, -0.00044148473534733057, -0.08388770371675491, -0.017837096005678177, -0.06151212379336357, 0.00606065709143877, -0.14553233981132507, -0.0006405316526070237, 0.0763077437877655, -0.16089102625846863, 0.07498052716255188, 0.012564469128847122, 0.003436808241531253, 0.10632822662591934, 0.04237442836165428, 0.026114268228411674, -0.16198399662971497, -0.05375654250383377, -0.048098012804985046, 0.01840967871248722, 0.10737483948469162, -0.22905075550079346, 0.0342956967651844, 0.08895016461610794], "changes": {"1wk": 3.2222217983669705}}, {"text": "PREMIUM Top Premarket Gainers MT Newswires Mon, Jan 27, 2025, 3:42 PM 1 min de lecture Dans cet article: JG +13.46% AKRO -0.43% Aurora Mobile (JG) shares were up over 200% pre-bell Monday after the company said its business-orie PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. R\u00e9viser \u00e0 la hausse Vous avez d\u00e9j\u00e0 un abonnement\u00a0? Se connecter CGU et Politique de confidentialit\u00e9 Privacy Dashboard Articles recommand\u00e9s", "symbol": "ETNB", "date": "2025-01-27T12:42:04+00:00", "sentiment": {"score": 0.6328720357269049, "confidence": 0.6489484906196594, "probabilities": {"positive": 0.6489484906196594, "negative": 0.016076454892754555, "neutral": 0.33497506380081177}}, "embedding": [-0.16626779735088348, -0.030515156686306, 0.02443549409508705, 0.09205090999603271, 0.03462948277592659, 0.10580457001924515, 0.12108089029788971, 0.07097190618515015, 0.05055221542716026, 0.11634093523025513, 0.06485696882009506, 0.1806991547346115, 0.03317730873823166, -0.09150370210409164, 0.09089550375938416, -0.061284419149160385, 0.07825729995965958, -0.04519670084118843, -0.14167220890522003, -0.012758404947817326, -0.18379299342632294, -0.13929735124111176, 0.0194330345839262, -0.07792671769857407, 0.2424807995557785, -0.036612674593925476, -0.08565948903560638, 0.030891327187418938, 0.09351983666419983, -0.11524707078933716, -0.02329321764409542, -0.041491299867630005, 0.18238237500190735, 0.02557644061744213, -0.10561144351959229, -0.10318458825349808, -0.028838127851486206, -0.08995549380779266, 0.0016572152962908149, 0.06064410135149956, 0.04903961718082428, -0.10784346610307693, -0.16713449358940125, -0.07854730635881424, -0.07550664991140366, 0.022724837064743042, -0.05043242499232292, 0.050855644047260284, -0.04612520709633827, 0.07509173452854156, -0.08061424642801285, -0.02015572600066662, 0.08791365474462509, -0.15664160251617432, -0.06273802369832993, -0.015644380822777748, -0.18697085976600647, -0.016064384952187538, 0.07331540435552597, -0.009919391945004463, -0.038893651217222214, -0.036195456981658936, -0.08380981534719467, 0.09391502290964127, 0.014004182070493698, -0.04936288297176361, 0.06477195024490356, 0.2244635373353958, -0.01792415790259838, -0.12108597159385681, 0.06511006504297256, 0.04551764205098152, -0.001757705002091825, 0.02093086577951908, -0.11271387338638306, 0.21399128437042236, 0.1367068886756897, -0.005965434480458498, -0.0008043391280807555, -0.08500123769044876, 0.06682169437408447, 0.018200131133198738, 0.0004024560912512243, -0.0010420335456728935, -0.05146500840783119, -0.05478796362876892, -0.013294419273734093, -0.027748774737119675, -0.0412982739508152, -0.03248119354248047, 0.08702166378498077, 0.05803409963846207, -0.06550111621618271, 0.07192274928092957, -0.12880581617355347, 0.08621881902217865, -0.16869908571243286, -0.14697840809822083, -0.08905971050262451, 0.1158163994550705, 0.10215486586093903, 0.17542684078216553, 0.05506860837340355, 0.0586618073284626, -0.08019880205392838, -0.1968049556016922, -0.05391259863972664, 0.10954952985048294, 0.03515365719795227, 0.14335466921329498, 0.02813338115811348, -0.055700287222862244, -0.06531126797199249, -0.1497040092945099, 0.012363716028630733, 0.02897304855287075, -0.08163434267044067, 0.008433608338236809, 0.16012951731681824, -0.0533023402094841, 0.059327222406864166, 0.03777991235256195, -0.03266717121005058, 0.023588264361023903, 0.016004936769604683, 0.11348269134759903, -0.05252879112958908, 2.0907126526638242e-32, -0.0799759104847908, 0.11132800579071045, -0.005736160092055798, -0.02452264167368412, -0.0938209593296051, 0.01730537600815296, -0.04151710867881775, -0.02907661721110344, -0.06094355508685112, 0.026567380875349045, -0.10261865705251694, 0.2356511801481247, -0.04717421904206276, -0.026007281616330147, -0.01320667564868927, -0.14979207515716553, -0.010679725557565689, 0.0023971523623913527, 0.07925347983837128, 0.006112384609878063, 0.08435051888227463, -0.054159462451934814, 0.008710072375833988, 0.08804985135793686, 0.04461789131164551, 0.052653755992650986, 0.07650946825742722, -0.14498496055603027, -0.051839493215084076, 0.09764587879180908, 0.029848551377654076, 0.042483191937208176, -0.012718233279883862, 0.011646117083728313, -0.033713001757860184, 0.036143165081739426, -0.10817233473062515, -0.08738693594932556, 0.01013842225074768, -0.13715864717960358, -0.06953848153352737, -0.12805548310279846, -0.1429363191127777, 0.014715457335114479, -0.06972377002239227, -0.02104535885155201, -0.09865967929363251, -0.10174771398305893, 0.11395387351512909, -0.0423072911798954, -0.13139337301254272, 0.034035664051771164, -0.1759081482887268, -0.007826900109648705, -0.011156341060996056, 0.12674970924854279, -0.03269428759813309, 0.03051178529858589, 0.16010642051696777, -0.018411682918667793, 0.03617360442876816, 0.10647459328174591, -0.01694919355213642, -0.03831053525209427, -0.1282886564731598, 0.06143740192055702, -0.05520600080490112, -0.07991104573011398, -0.04256516695022583, 0.11657831817865372, 0.13868503272533417, -0.03928663209080696, 0.14325888454914093, 0.0006554862484335899, -0.07141618430614471, 0.05482988804578781, -0.15515589714050293, 0.09007792919874191, 0.13732241094112396, 0.045515693724155426, 0.014424675144255161, -0.07710932195186615, 0.10176119953393936, 0.011854175478219986, 0.07049006223678589, -0.0314653255045414, 0.0801556184887886, -0.012509495951235294, 0.010950133204460144, 0.11488112062215805, 0.07836782932281494, 0.13084346055984497, -0.07052937150001526, 0.07916155457496643, -0.11395218968391418, -2.0638799369911916e-32, -0.08718717098236084, 0.07336332648992538, -0.1078965812921524, -0.005032483022660017, -0.05044633895158768, -0.0028255139477550983, -0.04049718752503395, 0.18276439607143402, -0.06372207403182983, 0.06883593648672104, -0.00043471541721373796, -0.00032871728762984276, 0.026754561811685562, -0.058853019028902054, 0.05872603878378868, -0.09108960628509521, 0.1628180742263794, -0.10166016221046448, -0.08614694327116013, 0.07882693409919739, -0.054596442729234695, 0.013547743670642376, -0.07744555175304413, 0.25278958678245544, 0.20712141692638397, -0.07934532314538956, 0.040854938328266144, 0.09170206636190414, -0.058017123490571976, 0.014521685428917408, -0.043503426015377045, 0.02919173240661621, -0.08026670664548874, 0.02601434290409088, 0.008056449703872204, -0.07130011171102524, 0.17737650871276855, 0.1503847986459732, -0.0231796782463789, -0.07857032865285873, 0.11210313439369202, -0.06085413694381714, 0.009770994074642658, 0.011164933443069458, 0.02264692634344101, 0.02123650349676609, -0.02472977340221405, -0.056440822780132294, 0.04150191694498062, -0.08826149255037308, -0.01183409709483385, 0.05116619914770126, 0.06935232132673264, 0.1391482949256897, -0.12142547965049744, 0.12067680060863495, -0.055302560329437256, -0.06777819991111755, -0.007538564037531614, 0.0584520623087883, 0.1180562973022461, 0.03323313966393471, -0.08257132768630981, -0.059475891292095184, 0.0009255330660380423, -0.0635288879275322, 0.10605419427156448, -0.06449688971042633, 0.028129035606980324, -0.053441304713487625, 0.061217259615659714, -0.0777011439204216, -0.0012687789276242256, -0.2614944279193878, 0.013020016252994537, 0.14518845081329346, -0.04244696721434593, -0.0027767233550548553, 0.001058176625519991, -0.05185310170054436, 0.012235901318490505, 0.11928252130746841, -0.1228744238615036, -0.02638610079884529, 0.05405004322528839, -0.024625569581985474, 0.09531603753566742, -0.11775873601436615, -0.15781424939632416, -0.03213977441191673, -0.11160919815301895, -0.0952368974685669, -0.09557688236236572, 0.08929259330034256, -0.04398627206683159, -1.0095008207144929e-07, 0.03191887587308884, -0.153693288564682, 0.06780470907688141, -0.02278456836938858, 0.20634078979492188, -0.10072121769189835, -0.028982318937778473, -0.004011175595223904, -0.04442596435546875, 0.19278889894485474, 0.029725490137934685, -0.062312398105859756, -0.1785392463207245, -0.021081535145640373, -0.01683148741722107, -0.013749445788562298, -0.010227774269878864, 0.1170915737748146, -0.05145294591784477, -0.09710630029439926, 0.1321224570274353, 0.06917902827262878, 0.05795967951416969, -0.11126694083213806, 0.09854946285486221, 0.03126617893576622, -0.010872161947190762, -0.056795258074998856, 0.15512408316135406, -0.04991577938199043, -0.1729448437690735, 0.02086246944963932, -0.03333849459886551, -0.07809590548276901, 0.004252188373357058, 0.11680861562490463, 0.08415115624666214, -0.06035487353801727, -0.05355242267251015, 0.01651361584663391, -0.0030626661609858274, -0.11154050379991531, 0.15202315151691437, 0.05089760571718216, -0.07637207955121994, 0.04020439088344574, -0.10633789002895355, -0.10468678176403046, 0.07814408838748932, -0.10372380167245865, -0.01320720836520195, -0.12211603671312332, 0.06720858812332153, 0.005268234759569168, -0.054693322628736496, 0.02209702879190445, 0.094820536673069, -0.06371652334928513, -0.06235813349485397, 0.10359185189008713, 0.07132665067911148, -0.1363992691040039, -0.056350212544202805, 0.06154468283057213], "changes": {"1wk": 6.666670905219184}}, {"text": "89bio Provides Business Update and Outlook for 2025 89bio, Inc. Mon, Jan 13, 2025, 4:00 PM 5 min read In This Article: ETNB -3.23% 89bio, Inc. \u2013 Completed enrollment in Phase 3 ENTRUST trial in patients with severe hypertriglyceridemia (SHTG); topline 26-week data expected in the second half of 2025 \u2013 \u2013 The Phase 3 ENLIGHTEN program in patients with non-cirrhotic (F2-F3) and compensated cirrhotic (F4) metabolic dysfunction-associated steatohepatitis (MASH) continues to enroll patients across both trials \u2013 \u2013 Cash, cash equivalents, and marketable securities totaled approximately $440 million as of December 31, 2024 \u2013 SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today provided a corporate update and business outlook for 2025. \u201cLooking ahead to 2025, we are well-positioned to build on the momentum from the initiation and ongoing enrollment of our ENLIGHTEN Phase 3 program in MASH and the successful completion of enrollment in our ENTRUST Phase 3 trial in SHTG and expect to announce topline data from the Company\u2019s first Phase 3 trial in the second half of 2025,\u201d said Rohan Palekar, CEO of 89bio. \u201cWe remain confident in pegozafermin\u2019s potential as a potent anti-fibrotic agent with broad cardio-metabolic benefits. With a strengthened leadership team, commercial-scale manufacturing available, and a bolstered financial position, we continue to advance our Phase 3 programs toward potential Biologics License Application (BLA) and Marketing Authorization Application (MAA) filings, aiming to transform care for patients living with MASH and SHTG.\u201d Key 2024 Highlights Completed enrollment in ENTRUST , the Phase 3 trial evaluating the efficacy, safety and tolerability of pegozafermin in patients with SHTG. 89bio expects to report topline 26-week data from this trial in the second half of 2025. Initiated ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis , the Phase 3 trials in non-cirrhotic (F2-F3) MASH patients with fibrosis and in compensated cirrhotic (F4) MASH patients,\u00a0in March and May of 2024, respectively. Both MASH studies continue to enroll patients globally. Obtained regulatory feedback from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on clinical as well as Chemistry, Manufacturing, and Controls (CMC) requirements for marketing authorization filings for pegozafermin. The Company remains on track for potential BLA and MAA filings, pending positive clinical data. Bolstered its balance sheet through the completed equity follow-on offering for $143.8 million in gross proceeds and an amended credit facility with K2 HealthVentures, providing an aggregate principal of up to $150.0 million. Cash, cash equivalents, and marketable securities totaled approximately $440 million as of December 31, 2024 (preliminary unaudited). Strengthened its executive leadership team and Board of Directors with four seasoned industry veterans. Appointments include Teresa Perney, Ph.D., Chief Regulatory and Quality Officer; Francis Sarena, Chief Operating Officer; Charles McWherter, Ph.D., Board of Directors; and Martin Babler, Board of Directors. These additions bring extensive operational, clinical, regulatory, and commercial expertise to 89bio. Story Continues About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on rapidly advancing its lead candidate, pegozafermin, through Phase 3 clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 (FGF21) analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco. For more information, visit www.89bio.com or follow the company on LinkedIn . Forward-looking Statements Certain statements in this press release may constitute \"forward-looking statements\" within the meaning of the federal securities laws, including, but not limited to, statements regarding the therapeutic potential and utility, efficacy and clinical benefits of pegozafermin, the safety and tolerability profile of pegozafermin, trial designs, clinical development plans and timing for pegozafermin, including the topline results from the ENTRUST Phase 3 trial in SHTG and enrollment in clinical trials, including enrollment of the Phase 3 ENLIGHTEN-Fibrosis trial and Phase 3 ENLIGHTEN-Cirrhosis trial in MASH and 89bio\u2019s potential BLA and MAA filings. Words such as \"may,\" \"might,\" \"will,\" \"objective,\" \"intend,\" \"should,\" \"could,\" \"can,\" \"would,\" \"expect,\" \"believe,\" \"design,\" \"estimate,\" \"predict,\" \"potential,\" \"anticipate,\" \"goal,\" \"opportunity,\" \"develop,\" \"plan\" or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements. While 89bio believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in 89bio's filings with the Securities and Exchange Commission (SEC)), many of which are beyond 89bio's control and subject to change. Actual results could be materially different. Risks and uncertainties include: expectations regarding the timing and outcome of the ENLIGHTEN-Fibrosis Phase 3 trial and Phase 3 ENLIGHTEN-Cirrhosis trial in MASH and ENTRUST Phase 3 trial in SHTG; 89bio's ability to execute on its strategy; positive results from a clinical study may not necessarily be predictive of the results of future or ongoing clinical studies; 89bio's substantial dependence on the success of it lead product candidate; competition from competing products; the impact of general economic, health, industrial or political conditions in the United States or internationally; the sufficiency of 89bio's capital resources and its ability to raise additional capital; and other risks and uncertainties identified in 89bio\u2019s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and other subsequent disclosure documents filed with the SEC. 89bio claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. 89bio expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. Investor Contact: Annie Chang 89bio, Inc. annie.chang@89bio.com PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 pkelleher@lifesciadvisors.com Media Contact : Sheryl Seapy Real Chemistry sseapy@realchemistry.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2025-01-13T13:00:00+00:00", "sentiment": {"score": 0.8798398608341813, "confidence": 0.887203574180603, "probabilities": {"positive": 0.887203574180603, "negative": 0.007363713346421719, "neutral": 0.10543273389339447}}, "embedding": [-0.06379003822803497, -0.14115452766418457, -0.029627230018377304, -0.06001162901520729, -0.013089270330965519, -0.08610326051712036, -0.1213759034872055, 0.23877111077308655, 0.0546438954770565, -0.0038808872923254967, -0.08563020825386047, -0.0016400497406721115, -0.0033841896802186966, -0.039697229862213135, 0.03811241313815117, -0.11582766473293304, 0.11898438632488251, -0.051913511008024216, -0.03698351979255676, 0.03349054977297783, 0.06510229408740997, -0.00849979743361473, 0.04971538484096527, 0.045510098338127136, -0.05718391016125679, 0.016219770535826683, -0.07605616748332977, -0.0017070779576897621, -0.19420349597930908, -0.0004562530666589737, 0.09066635370254517, 0.16561147570610046, 0.08049116283655167, -0.08506596088409424, 0.021696124225854874, -0.01882612705230713, -0.1058034598827362, 0.12428370118141174, -0.10519570857286453, -0.13059227168560028, 0.00573346670717001, -0.04255136847496033, -0.1221170574426651, 0.09796295315027237, 0.13123644888401031, -0.2915332317352295, -0.06243357062339783, 0.0541037917137146, -0.0058057717978954315, 0.24274498224258423, -0.20980936288833618, -0.19277998805046082, 0.05947336554527283, 0.15794675052165985, -0.022849129512906075, -0.0610370934009552, -0.043871816247701645, -0.06994441151618958, -0.019877800717949867, -0.0589534193277359, -0.11280310899019241, -0.018875032663345337, -0.03800385817885399, -0.05688609555363655, 0.08469422161579132, -0.03204112499952316, 0.022400202229619026, -0.033337365835905075, -0.005131326615810394, -0.05738060921430588, 0.06356887519359589, -0.1568431556224823, 0.014900049194693565, 0.1187254935503006, -0.04667246714234352, 0.14963263273239136, 0.0717829093337059, 0.08674904704093933, 0.10699671506881714, -0.08146550506353378, 0.10225805640220642, 0.01298462599515915, 0.09582309424877167, 0.011386220343410969, -0.08497681468725204, -0.010569369420409203, -0.07483255118131638, 0.18054983019828796, -0.03032623417675495, -0.002363930456340313, 0.11059266328811646, 0.044591616839170456, 0.09236077964305878, 0.015039365738630295, -0.025693248957395554, -0.013042064383625984, -0.20528468489646912, -0.07908381521701813, 0.06620743870735168, 0.03759981691837311, 0.014818602241575718, 0.054839473217725754, -0.05726316571235657, -0.12620572745800018, -0.011266795918345451, -0.08973854780197144, 0.06806676089763641, 0.009692005813121796, 0.057265039533376694, 0.004575821571052074, -0.0452963262796402, -0.006449160166084766, 0.06872780621051788, -0.03133082389831543, -0.06494985520839691, 0.2933935821056366, -0.10262800008058548, 0.06809030473232269, 0.23556044697761536, 0.057707641273736954, 0.07183593511581421, 0.11577138304710388, 0.10130047798156738, -0.1449405550956726, 0.06599956750869751, 0.08460982143878937, -0.09832367300987244, 7.673447859279392e-33, -0.01902594044804573, 0.03130752593278885, 0.05618486553430557, 0.07372333854436874, 0.06410403549671173, -0.028473127633333206, 0.09829585999250412, 0.02677883580327034, -0.10174402594566345, -0.07721054553985596, -0.11058211326599121, 0.02909763529896736, -0.01874241605401039, 0.1380496323108673, -0.12502098083496094, -0.1389659345149994, -0.10383283346891403, 0.08042039722204208, 0.03931353613734245, 0.08487202227115631, 0.017342977225780487, -0.08659568428993225, 0.029866646975278854, -0.004808541387319565, -0.022052723914384842, 0.2124704122543335, -0.022834260016679764, 0.09930609911680222, 0.13369473814964294, 0.07203499972820282, -0.05225023999810219, 0.08698190003633499, 0.05656350404024124, -0.2108178287744522, -0.044773560017347336, -0.05543528497219086, -0.025465495884418488, -0.14408215880393982, -0.0293938796967268, 0.07137444615364075, 0.013031632639467716, 0.07563566416501999, -0.041585251688957214, -0.13935306668281555, 0.1101662814617157, -0.0852179005742073, -0.08354689180850983, 0.016553904861211777, 0.05470021814107895, 0.06099817156791687, 0.02228512056171894, -0.10502291470766068, 0.06837724149227142, -0.018005045130848885, -0.04390288144350052, -0.01468283124268055, -0.13183432817459106, -0.028532231226563454, 0.04167177155613899, 0.05037534236907959, 0.08759782463312149, 0.11864610016345978, -0.026069238781929016, 0.011690222658216953, -0.1746990978717804, 0.0893716961145401, -0.05838508903980255, -0.10935694724321365, -0.1775628924369812, 0.10939805209636688, -0.0023857103660702705, -0.03699030354619026, 0.13750727474689484, 0.04743780568242073, 0.08586401492357254, -0.06250977516174316, 0.014766613021492958, 0.10996870696544647, 0.017723185941576958, -0.04250220209360123, 0.0018159039318561554, -0.006258070468902588, -0.18980151414871216, 0.13063645362854004, 0.05576198548078537, 0.009532442316412926, 0.012968153692781925, 0.02372501790523529, -0.19663995504379272, -0.07899273186922073, 0.12085209041833878, 0.09003546833992004, -0.07840549200773239, 0.29369276762008667, -0.019864559173583984, -8.763667441789216e-33, -0.03549160063266754, 0.0018214532174170017, -0.04557904601097107, -0.054348547011613846, 0.012608352117240429, 0.07557933032512665, 0.016536707058548927, -0.11078965663909912, 0.19034144282341003, -0.17516791820526123, 0.04385176673531532, 0.06198068708181381, 0.00378273893147707, -0.08215423673391342, -0.09177467226982117, 0.04571498930454254, -0.0002548098564147949, -0.15719106793403625, -0.08125170320272446, 0.02495002932846546, 0.08147913962602615, 0.1334121972322464, -0.0951663926243782, 0.1373591423034668, 0.025549087673425674, 0.06199710816144943, 0.19432565569877625, 0.09452418237924576, 0.09192007780075073, -0.02293395809829235, -0.07196439802646637, 0.02006722241640091, -0.29190364480018616, -0.01543998159468174, -0.13240447640419006, 0.029331885278224945, 0.07890386134386063, -0.1225854754447937, -0.018377218395471573, -0.047561705112457275, 0.062313616275787354, 0.07785335928201675, -0.07716365903615952, 0.0012506674975156784, 0.012552140280604362, 0.034583233296871185, 0.12667949497699738, -0.06915422528982162, 0.22734004259109497, 0.03898957371711731, -0.01951151341199875, -0.09334321320056915, 0.04435242712497711, 0.01851341500878334, -0.08038696646690369, -0.02618807554244995, 0.027833128347992897, 0.01718698814511299, -0.07932679355144501, 0.02604364976286888, -0.04540484398603439, 0.15081864595413208, 0.09237630665302277, 0.043852999806404114, 0.08855585753917694, 0.1645984649658203, 0.14009757339954376, -0.045187439769506454, 0.12559959292411804, -0.10280255973339081, -0.15775805711746216, -0.1418517827987671, -0.12636178731918335, -0.05980799347162247, 0.05791382119059563, 0.1556275188922882, -0.034911010414361954, -0.10927927494049072, -0.15531903505325317, -0.1262846291065216, -0.007010397035628557, -0.11399802565574646, -0.015043014660477638, 0.08725067973136902, 0.016179915517568588, -0.02123725414276123, -0.04352719336748123, -0.09983013570308685, 0.004793521948158741, 0.08414150029420853, -0.14667703211307526, -0.04416266083717346, -0.11455702781677246, 0.04060332849621773, 0.002858515828847885, -1.0071707379211148e-07, 0.12236209958791733, -0.11166003346443176, 0.031209729611873627, -0.044839926064014435, 0.003219146281480789, -0.0416468009352684, -0.052847351878881454, 0.014265678822994232, 0.0228838212788105, 0.07931798696517944, 0.06868654489517212, 0.22458158433437347, -0.08566487580537796, -0.05741116404533386, -0.0008819822687655687, 0.0739419162273407, 0.012282297015190125, 0.09114648401737213, -0.07170794904232025, 0.005483968183398247, -0.1670534461736679, 0.03739452362060547, 0.06916888803243637, -0.10385435819625854, 0.053890570998191833, -0.07634127140045166, 0.014827178791165352, 0.10451246798038483, 0.044817183166742325, -0.009837903082370758, 0.0055817193351686, -0.018138859421014786, 0.05335346609354019, 0.04332323744893074, -0.06313298642635345, -0.21776026487350464, -0.0009489655494689941, 0.06670092046260834, 0.04598388075828552, 0.08134258538484573, -0.02004699595272541, 0.012682303786277771, -0.131108820438385, -0.052239760756492615, -0.04992871358990669, -0.06083494424819946, -0.16885221004486084, 0.11060044169425964, -0.02510850504040718, -0.08875720202922821, -0.027219563722610474, 0.02266101911664009, -0.016236841678619385, -0.004790797829627991, -0.05265595763921738, 0.1366022825241089, -0.0841110348701477, -0.07454219460487366, 0.03660481423139572, -0.054411500692367554, 0.17437896132469177, -0.21617265045642853, 0.024433963000774384, 0.0015217773616313934], "changes": {"1wk": 0.0}}, {"text": "New Strong Sell Stocks for January 7th Zacks Equity Research Tue, Jan 7, 2025, 11:17 AM 1 min read In This Article: ETNB -3.23% ATUS -2.14% ASH -4.10% Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: 89bio, Inc. ETNB is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 38.8% downward over the last 60 days. Altice USA, Inc. ATUS is a broadband communications and video services provider. The Zacks Consensus Estimate for its current year earnings has been revised 250% downward over the last 60 days. Ashland Inc. ASH is a additives and specialty ingredients provider.The Zacks Consensus Estimate for its current year earnings has been revised 16.2% downward over the last 60 days. View the entire Zacks Rank #5 List. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ashland Inc. (ASH) : Free Stock Analysis Report Altice USA, Inc. (ATUS) : Free Stock Analysis Report 89BIO (ETNB) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2025-01-07T08:17:00+00:00", "sentiment": {"score": -0.28136444464325905, "confidence": 0.30886778235435486, "probabilities": {"positive": 0.02750333771109581, "negative": 0.30886778235435486, "neutral": 0.663628876209259}}, "embedding": [-0.17670229077339172, -0.18933407962322235, -0.02053077518939972, 0.0898030549287796, 0.0945449024438858, -0.017795205116271973, -0.08081303536891937, 0.1802639663219452, -0.08116243034601212, 0.0076649971306324005, -0.05044497177004814, 0.14366476237773895, -0.036426570266485214, -0.09334375709295273, -0.058091916143894196, 0.003116216976195574, 0.18016868829727173, -0.1402161568403244, -0.11582015454769135, -0.06055479496717453, -0.00735793262720108, -0.006399393547326326, 0.04136181250214577, -0.07717808336019516, 0.14820022881031036, 0.022851524874567986, -0.08149708062410355, -0.031725745648145676, 0.019650137051939964, -0.13294102251529694, -0.05612988770008087, -0.011818391270935535, 0.11839340627193451, -0.06800591200590134, -0.14534622430801392, -0.1068354994058609, -0.011140203103423119, 0.08420280367136002, 0.08494311571121216, -0.06243205443024635, 0.047729745507240295, 0.04864506423473358, -0.11531965434551239, -0.1047130674123764, -0.10656646639108658, -0.16259507834911346, 0.08061745017766953, -0.06145349144935608, 0.057140860706567764, 0.03778136149048805, -0.08980122953653336, -0.143113911151886, 0.0664173811674118, 0.006102589424699545, -0.1288234442472458, -0.11853612959384918, -0.17222370207309723, -0.2087039053440094, 0.014876576140522957, -0.05005188286304474, 0.18633335828781128, -0.05584443360567093, 0.03765437752008438, 0.05545160919427872, 0.06571928411722183, 0.03500921651721001, 0.02124037779867649, 0.04478003829717636, -0.011733999475836754, 0.0015001260908320546, 0.016080116853117943, -0.059696830809116364, -0.0772138237953186, 0.150406613945961, -0.08469199389219284, 0.14804549515247345, 0.17048698663711548, 0.04358452931046486, 0.10821773111820221, -0.11582130938768387, -0.014754301868379116, -0.045401182025671005, 0.03434757515788078, -0.03289279341697693, 0.08121145516633987, 0.012084536254405975, -0.015954844653606415, 0.116836316883564, -0.05029161646962166, -0.006008740980178118, 0.15794497728347778, 0.09871108829975128, 0.14064109325408936, -0.00017934855713974684, 0.03127061203122139, 0.0006999074248597026, -0.07856795936822891, 0.01966596394777298, -0.1699831783771515, 0.04284842684864998, 0.0518881231546402, 0.31849581003189087, -0.1279054433107376, -0.08427033573389053, -0.0808137059211731, -0.14324824512004852, 0.055349208414554596, 0.01413470134139061, 0.02263222448527813, 0.14349594712257385, 0.02403147891163826, 0.0750860795378685, -0.05471169576048851, -0.024279845878481865, -0.14321297407150269, 0.0837196335196495, -0.08797331899404526, -0.03678654134273529, 0.16151537001132965, 0.02278849296271801, 0.007291540037840605, 0.16344834864139557, -0.04340313374996185, 0.05004435032606125, 0.08605558425188065, 0.016745474189519882, -0.14169842004776, 1.1202566957827974e-32, -0.04687714949250221, 0.18175657093524933, -0.06550145149230957, -0.018346864730119705, -0.0007714857347309589, 0.060910914093256, 0.014728737063705921, -0.039803262799978256, -0.08857004344463348, 0.05329529568552971, -0.2669941782951355, 0.15338532626628876, -0.02684863843023777, -0.006018150597810745, -0.06265106052160263, -0.06198569014668465, 0.05508008226752281, 0.012154320254921913, 0.09133708477020264, -0.13347934186458588, 0.013016941957175732, -0.10902686417102814, -0.048363097012043, -0.02631605975329876, 0.06591258198022842, -0.0369911789894104, -0.012938160449266434, 0.03153136745095253, -0.14597561955451965, 0.08035065978765488, -0.016758045181632042, 0.02765987254679203, -0.1321941763162613, -0.0399334616959095, -0.03750670328736305, -0.07033728808164597, -0.07196690887212753, 0.0599794015288353, 0.06866705417633057, 0.03396575525403023, -0.008942806161940098, 0.17748534679412842, -0.12689974904060364, -0.007599774748086929, 0.05013253539800644, 0.08986631780862808, -0.15617738664150238, 0.13179728388786316, 0.10443232208490372, 0.050765763968229294, -0.14271409809589386, -0.03803640976548195, 0.03855031728744507, 0.008483466692268848, -0.09909313917160034, 0.037191346287727356, -0.011331840418279171, -0.06009287387132645, 0.06601999700069427, 0.07908077538013458, 0.12117401510477066, 0.19210971891880035, -0.035386502742767334, -0.020800335332751274, -0.2965291142463684, 0.084229975938797, -0.016570940613746643, 0.013922581449151039, -0.14944961667060852, 0.14569656550884247, 0.097032830119133, 0.05614229664206505, 0.1671973317861557, -0.020325666293501854, 0.05513262376189232, -0.07014074176549911, -0.015422744676470757, -0.023261113092303276, 0.08384142071008682, 0.1087741106748581, 0.06399530172348022, -0.03903500363230705, 0.002528674900531769, -0.015285604633390903, 0.016261672601103783, -0.0711856484413147, 0.050945308059453964, 0.06294306367635727, -0.014434917829930782, 0.06839319318532944, 0.034698475152254105, -0.02781463973224163, -0.1009429320693016, 0.11054656654596329, -0.04500313848257065, -9.770067664929686e-33, -0.016880180686712265, 0.01240687258541584, -0.024435367435216904, -0.028353000059723854, -0.0623503215610981, 0.024499034509062767, 0.11285950988531113, 0.10303213447332382, 0.08580987900495529, -0.07427968084812164, 0.21662069857120514, 0.06075769662857056, -0.029107045382261276, 0.00020248940563760698, 0.03168405219912529, -0.03635341674089432, 0.009226126596331596, -0.08574634790420532, 0.09221887588500977, -0.12066402286291122, -0.016625992953777313, 0.09139914810657501, -0.12566009163856506, 0.20531168580055237, -0.028808649629354477, 0.037020403891801834, -0.0013276251265779138, 0.09533671289682388, 0.021268248558044434, 0.00032219846616499126, -0.018615741282701492, 0.03346455097198486, -0.06916747987270355, 0.19516587257385254, -0.19690215587615967, 0.05196513235569, 0.10622445493936539, -0.11649352312088013, -0.031222118064761162, -0.08838551491498947, 0.13229694962501526, 0.09895046055316925, -0.07159729301929474, 0.027130350470542908, 0.0356462188065052, 0.0870574563741684, 0.01784188486635685, -0.023486120626330376, 0.028956713154911995, -0.049061764031648636, 0.14140021800994873, -0.04455491155385971, -0.003361704759299755, 0.19232779741287231, -0.0016688379691913724, 0.058970220386981964, 0.047746770083904266, 0.019995778799057007, -0.2577953338623047, -0.03774230554699898, 0.021722974255681038, 0.2013215720653534, -0.10989724099636078, 0.07409577816724777, -0.052707843482494354, 0.019227750599384308, 0.016808172687888145, -0.05759463086724281, -0.035891711711883545, -0.12943412363529205, -0.012157983146607876, -0.1686374396085739, -0.010779204778373241, -0.15252059698104858, -0.05710109695792198, 0.1814243048429489, 0.03520289435982704, -0.1627645641565323, -0.10943952947854996, -0.06482229381799698, -0.038266029208898544, 0.03379342332482338, -0.005323604214936495, 0.07758010178804398, 0.03836996480822563, 0.12682484090328217, -0.0038815774023532867, 0.04962613061070442, 0.06635945290327072, 0.028142793104052544, -0.09862449765205383, -0.1211552768945694, -0.2179385870695114, 0.08883566409349442, 0.13839992880821228, -9.974380077437672e-08, 0.07069612294435501, -0.12893535196781158, 0.040939442813396454, 0.03837926685810089, 0.06038089096546173, -0.04858103767037392, 0.07328549772500992, 0.03864176943898201, 0.029127974063158035, 0.07209520787000656, 0.04912247881293297, 0.007145954295992851, -0.20902122557163239, 0.001186247682198882, -0.012176461517810822, -0.025814156979322433, -0.057523611932992935, 0.09179484844207764, 0.02794942632317543, -0.16168427467346191, -0.02191990055143833, 0.12090911716222763, 0.2520388662815094, -0.08194275200366974, 0.05518001690506935, 0.0019280982669442892, -0.06097555533051491, -0.07125141471624374, 0.07846136391162872, -0.0011435989290475845, -0.004040549509227276, -0.012623265385627747, 0.07738624513149261, -0.018227670341730118, -0.020186832174658775, -0.04004015773534775, 0.0817488357424736, -0.0013223811984062195, 0.04269317537546158, 0.030235083773732185, -0.06559986621141434, -0.08247797936201096, -0.1451764702796936, -0.03190460056066513, 0.01779921166598797, -0.011936991475522518, -0.08113054186105728, 0.03649355098605156, 0.1591615527868271, -0.19292020797729492, 0.12671084702014923, -0.1047147810459137, 0.11712927371263504, 0.002596951322630048, -0.07640860974788666, 0.03580415993928909, -0.1831277757883072, -0.07723016291856766, -0.008957920596003532, 0.02184777893126011, 0.20952032506465912, -0.24912339448928833, -0.06224626302719116, 0.06050381436944008], "changes": {"1wk": -14.72973160189897}}, {"text": "89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 89bio, Inc. Fri, Dec 20, 2024, 12:05 AM 2 min read In This Article: ETNB -3.23% 89bio, Inc. SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the \u201cCompany\u201d or \u201c89bio\u201d) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company\u2019s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 48,000 shares of the Company\u2019s common stock to one new employee (the \u201cInducement Grant\u201d) on December 13, 2024 (the \u201cGrant Date\u201d). The Inducement Grant has been granted pursuant to the Company\u2019s 2023 Inducement Plan (the \u201cPlan\u201d). The Inducement Grant was granted as an inducement material to the individual entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4). The Inducement Grant has an exercise price per share that is equal to the closing price of 89bio\u2019s common stock on the Grant Date. The Inducement Grant will vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the employee\u2019s start date, and thereafter the remainder of the shares vest in 12 equal quarterly installments, subject to the employee\u2019s continued employment with 89bio through the applicable vesting dates. About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on rapidly advancing its lead candidate, pegozafermin, through Phase 3 clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 (FGF21) analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco. For more information, visit www.89bio.com or follow the company on LinkedIn . Investor Contact: Annie Chang 89bio, Inc. investors@89bio.com PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 pkelleher@lifesciadvisors.com Media Contact: Sheryl Seapy Real Chemistry sseapy@realchemistry.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2024-12-19T21:05:00+00:00", "sentiment": {"score": 0.06796861160546541, "confidence": 0.0782875120639801, "probabilities": {"positive": 0.0782875120639801, "negative": 0.01031890045851469, "neutral": 0.9113935828208923}}, "embedding": [-0.06790725886821747, -0.04899255931377411, 0.016353314742445946, -0.06865106523036957, -0.1160476878285408, 0.10654491186141968, -0.03417505323886871, 0.2140495628118515, 0.0117730051279068, 0.012099924497306347, -0.00576707161962986, 0.01177870575338602, -0.004851971752941608, 0.025442451238632202, -0.04992946237325668, -0.004800702445209026, -0.006760607939213514, -0.016945552080869675, -0.12298807501792908, 0.05353209376335144, 0.018091566860675812, -0.013556252233684063, -0.02628837153315544, -0.07043705880641937, 0.011755391955375671, -0.00020876899361610413, -0.03597184643149376, 0.03937191516160965, -0.08018757402896881, -0.0015979912132024765, 0.08880017697811127, 0.17032450437545776, 0.10472811758518219, -0.15207773447036743, -0.08830113708972931, -0.013828646391630173, -0.13968297839164734, 0.10565201938152313, -0.054794248193502426, -0.0501260980963707, -0.05218946933746338, -0.0448991097509861, 0.030379578471183777, 0.12265768647193909, 0.05165340378880501, -0.18097122013568878, -0.011034109629690647, 0.07253772020339966, -0.02254284732043743, 0.1270160675048828, -0.06963227689266205, -0.1089555099606514, 0.04027478024363518, 0.20609188079833984, -0.018733974546194077, -0.012416462413966656, -0.0796428769826889, -0.0742058977484703, 0.040801964700222015, -0.03204762563109398, -0.05203033983707428, -0.06072945520281792, 0.02045731246471405, -0.07994695007801056, 0.06542997062206268, -0.07782341539859772, 0.029299668967723846, -0.05616158992052078, 0.027626371011137962, -0.014313087798655033, 0.15195371210575104, -0.11315033584833145, -0.042066607624292374, 0.1265849769115448, -0.06995261460542679, 0.2630653381347656, 0.05734637752175331, 0.17107999324798584, 0.12425687909126282, -0.17954197525978088, -0.034131549298763275, 0.029353156685829163, 0.06967595219612122, -0.052616994827985764, -0.022455397993326187, -0.037302423268556595, -0.041918352246284485, 0.094259113073349, 0.051195178180933, 0.07062088698148727, 0.1059807613492012, 0.036026425659656525, 0.002556523308157921, -0.0971762090921402, -0.034662604331970215, -0.13648077845573425, -0.12240919470787048, -0.04438665509223938, 0.018298082053661346, 0.05231411010026932, 0.07830850780010223, 0.07043670117855072, -0.1995604932308197, -0.015949048101902008, -0.041103169322013855, -0.09824756532907486, -0.003166564041748643, 0.021812941879034042, 0.03453492000699043, -0.0038272973615676165, -0.08944612741470337, -0.018123062327504158, 0.003731666598469019, -0.04387528821825981, -0.1969144344329834, 0.22899989783763885, -0.011915434151887894, -0.00953779648989439, 0.16943909227848053, 0.00830126367509365, 0.10160449147224426, 0.10728785395622253, 0.04772113263607025, -0.09475724399089813, -0.05334708094596863, -0.06823037564754486, -0.18092259764671326, 5.102305228773127e-33, 0.024387411773204803, -0.10522735118865967, -0.021630264818668365, 0.030173804610967636, 0.10839280486106873, -0.049086689949035645, 0.037891753017902374, -0.004243739414960146, -0.1327797919511795, -0.003337860107421875, -0.16821202635765076, 0.06384892761707306, 0.01588904857635498, 0.09768512845039368, -0.04980059713125229, -0.06750256568193436, -0.0282145868986845, 0.08615212887525558, 0.07041750848293304, 0.011698524467647076, 0.07250675559043884, 0.04864353686571121, -0.008901387453079224, 0.06458340585231781, 0.09589768946170807, 0.06019794940948486, -0.029705476015806198, 0.07135532051324844, -0.009249258786439896, 0.05988599359989166, -0.022856807336211205, 0.007841698825359344, -0.037445563822984695, -0.26943281292915344, -0.019488822668790817, -0.09113255143165588, -0.020967252552509308, -0.11562560498714447, 0.0586533360183239, -0.020816223695874214, 0.050354015082120895, 0.0056134797632694244, -0.056344494223594666, -0.17964833974838257, 0.05688821151852608, -0.011759499087929726, -0.01766921766102314, 0.09923326969146729, 0.030442383140325546, 0.13152813911437988, 0.03265045955777168, -0.10537289083003998, 0.06156808137893677, -0.05327124893665314, -0.08380452543497086, -0.017088565975427628, -0.21727488934993744, 0.07771272957324982, 0.14752426743507385, 0.09559432417154312, 0.07277535647153854, 0.18649160861968994, -0.07101304829120636, 0.15585225820541382, -0.19430769979953766, 0.06868170946836472, -0.003379873465746641, -0.13852372765541077, -0.019320521503686905, 0.11781363189220428, -0.014252726919949055, -0.002478223294019699, 0.15064199268817902, -0.012766740284860134, 0.016022691503167152, -0.09072992205619812, 0.027077926322817802, 0.13699163496494293, 0.040377531200647354, -0.07908977568149567, -0.018160050734877586, -0.008301641792058945, -0.1297006756067276, 0.09381021559238434, 0.05622992292046547, 0.03161051869392395, 0.011436949484050274, 0.12891191244125366, -0.17901049554347992, -0.07191476970911026, 0.1306341588497162, 0.030499691143631935, -0.030286770313978195, 0.21884292364120483, 0.055841345340013504, -5.331687155630757e-33, -0.020806830376386642, -0.044554539024829865, -0.06947031617164612, -0.10921256989240646, 0.10501944273710251, 0.10548847913742065, 0.02908209152519703, -0.11216405034065247, 0.0724504217505455, -0.1235411986708641, 0.03194389492273331, 0.07870785892009735, 0.056958653032779694, -0.08094756305217743, -0.11635079979896545, 0.026142388582229614, -0.036096420139074326, -0.08419378101825714, -0.07534454017877579, 0.013082282617688179, 0.018403075635433197, 0.173996701836586, -0.03924575448036194, 0.11958017945289612, 0.06190027669072151, 0.06312436610460281, 0.04642729461193085, 0.20845767855644226, 0.022374510765075684, 0.1525322049856186, -0.119988352060318, 0.009723769500851631, -0.33569300174713135, 0.08518091589212418, -0.07396917045116425, -0.11923976242542267, 0.13707882165908813, -0.09362050145864487, 0.09327664971351624, -0.008880995213985443, 0.07305780798196793, 0.03570975735783577, 0.0627388283610344, 0.15264950692653656, 0.03209365904331207, -0.029482461512088776, 0.08422106504440308, -0.13224735856056213, 0.15900003910064697, -0.002826881594955921, -0.007469426840543747, -0.06787135452032089, 0.15283769369125366, 0.07874547690153122, -0.0010453294962644577, 0.0018549878150224686, 0.05737925320863724, -0.048236098140478134, 0.05954396724700928, -0.02782626822590828, 0.04508525878190994, 0.07401995360851288, 0.052198756486177444, 0.0012312326580286026, 0.1200256198644638, 0.06871145218610764, 0.09300410747528076, -0.012686843052506447, 0.05735871568322182, -0.09843625873327255, -0.01394590362906456, -0.07245704531669617, 0.051298588514328, -0.01824907399713993, 0.0782148540019989, 0.14823031425476074, 0.09292463958263397, -0.12090972065925598, -0.14541682600975037, 0.021893229335546494, -0.07171459496021271, -0.08858498930931091, 0.00034326501190662384, 0.12309413403272629, -0.042062994092702866, -0.013420497067272663, 0.0058732349425554276, 0.05142127722501755, 0.044038087129592896, 0.061078790575265884, -0.167942613363266, -0.07938070595264435, -0.03483736515045166, 0.022206315770745277, -0.07857857644557953, -1.0026774788229886e-07, 0.06546541303396225, -0.15190361440181732, -0.06772840023040771, -0.12602224946022034, 0.07758618891239166, -0.09182894229888916, -0.11981812119483948, 0.05462058633565903, 0.01783066987991333, -0.009966472163796425, 0.08078610152006149, 0.2681998610496521, -0.08011230826377869, -0.0020508470479398966, -0.08087126910686493, -0.0607592836022377, -0.014359632506966591, 0.03472638502717018, -0.13118016719818115, -0.06588202714920044, -0.15395091474056244, 0.030017415061593056, 0.05832603573799133, -0.057833656668663025, -0.03411585092544556, -0.0912855714559555, 0.07502396404743195, 0.07925983518362045, -0.0021423627622425556, -0.009679531678557396, 0.07078371942043304, 0.04185721278190613, 0.05039031058549881, 0.03860771283507347, -0.1444377899169922, -0.10293930023908615, 0.07198037207126617, 0.022528912872076035, -0.014872265979647636, 0.09982700645923615, -0.02206157147884369, -0.04223969951272011, -0.07303499430418015, -0.04316820576786995, -0.011126206256449223, -0.07919614017009735, -0.21621379256248474, 0.030194662511348724, -0.08474576473236084, -0.16240330040454865, 0.07759851217269897, 0.04965207725763321, -0.09564238786697388, 0.0014515891671180725, -0.04777442291378975, 0.07044492661952972, -0.09802408516407013, -0.08214246481657028, 0.015135732479393482, -0.05401921272277832, 0.05278150737285614, -0.08479976654052734, 0.1278773844242096, -0.037966854870319366], "changes": {"1wk": 13.94025590079183, "1mo": -10.241824260890557}}, {"text": "New Strong Sell Stocks for November 16th Zacks Equity Research Mon, Dec 16, 2024, 1:59 PM 1 min read In This Article: HZO -2.73% Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ClevelandCliffs CLF is the largest producer of iron ore pellets in North America. The Zacks Consensus Estimate for its current year earnings has been revised almost 84.6% downward over the last 60 days. 89BIO ETNB is clinical-stage biopharmaceutical company which is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 36.2% downward over the last 60 days. MarineMax HZO is the nation's largest recreational boat and yacht retailer. The Zacks Consensus Estimate for its current year earnings has been revised 24.6% downward over the last 60 days. View the entire Zacks Rank #5 List. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cleveland-Cliffs Inc. (CLF) : Free Stock Analysis Report MarineMax, Inc. (HZO) : Free Stock Analysis Report 89BIO (ETNB) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2024-12-16T10:59:00+00:00", "sentiment": {"score": -0.2900499701499939, "confidence": 0.3198677897453308, "probabilities": {"positive": 0.029817819595336914, "negative": 0.3198677897453308, "neutral": 0.6503143906593323}}, "embedding": [-0.10549347847700119, -0.07879694551229477, -0.03608819097280502, 0.06630782783031464, 0.08843135833740234, -0.09343190491199493, -0.13121040165424347, 0.15372054278850555, -0.1812533587217331, -0.053155358880758286, -0.02269376628100872, 0.08487388491630554, -0.028739208355545998, 0.00037880954914726317, -0.04217071086168289, 0.0262040626257658, 0.24314500391483307, -0.0863538607954979, -0.138427734375, 0.07756666094064713, -0.1023167222738266, -0.01526806503534317, 0.055998094379901886, -0.021736301481723785, -0.05098501592874527, 0.1099376231431961, -0.11312989145517349, 0.10631032288074493, -0.05692310258746147, -0.03128119930624962, -0.18448662757873535, 0.06607265025377274, 0.11583341658115387, -0.026485875248908997, -0.012269529514014721, -0.05315067991614342, 0.04901426285505295, -0.04792241379618645, -0.009792633354663849, 0.02875816822052002, -0.0027882112190127373, 0.059394266456365585, -0.02276470698416233, -0.11881662160158157, -0.0931948721408844, -0.19615617394447327, 0.06266248226165771, -0.044124800711870193, 0.11083756387233734, 0.13730493187904358, -0.17260169982910156, -0.17762160301208496, 0.08867909759283066, 0.05149948596954346, -0.050023242831230164, -0.09443572163581848, -0.2641304135322571, -0.18688157200813293, 0.031279392540454865, -0.05988040566444397, 0.1330135613679886, 0.008300820365548134, 0.012719310820102692, 0.057135727256536484, 0.13939765095710754, -0.022091230377554893, -0.0618954636156559, 0.07610142230987549, -0.10680261999368668, -0.04188811779022217, 0.09650162607431412, -0.08042178303003311, -0.09715191274881363, 0.08604493737220764, -0.08628302067518234, 0.1852944791316986, 0.12867172062397003, -0.00914734322577715, 0.09895339608192444, -0.08705433458089828, -0.06200801581144333, -0.12036830931901932, 0.05580752342939377, -0.14739054441452026, -0.008313610218465328, 0.05539565905928612, 0.026280269026756287, 0.09795689582824707, -0.05055250972509384, 0.07546131312847137, 0.14521834254264832, 0.06965477764606476, 0.04366661235690117, -0.003593364730477333, -0.074832022190094, 0.09284253418445587, -0.0851849690079689, 0.12592284381389618, -0.14508186280727386, 0.06164201349020004, 0.10008009523153305, 0.24714145064353943, -0.026697253808379173, -0.11063734441995621, 0.042790286242961884, -0.12253089994192123, 0.14938613772392273, 0.16802158951759338, -0.07154267281293869, 0.08277996629476547, -0.02065655216574669, 0.1768750548362732, -0.09073470532894135, -0.00432564364746213, -0.12208949774503708, 0.15415368974208832, -0.08932197093963623, 0.03799421712756157, 0.1690620630979538, 0.08177585899829865, 0.11636965721845627, 0.20058637857437134, -0.018381698057055473, 0.007051760796457529, 0.0827612578868866, 0.07542236894369125, -0.09998680651187897, 1.0828911099164155e-32, -0.037052545696496964, 0.10626961290836334, 0.031370729207992554, -0.034796688705682755, -0.004774750676006079, 0.018211906775832176, -0.04353000223636627, -0.08879503607749939, -0.030901610851287842, 0.03955307975411415, -0.21991509199142456, 0.11977095901966095, 0.01325521431863308, 0.017575977370142937, -0.040826648473739624, -0.22902606427669525, 0.04550883546471596, -0.08300875872373581, 0.09191545844078064, -0.13166938722133636, 0.1467408537864685, -0.03407511115074158, -0.0043073128908872604, -0.06756389141082764, -0.03613753989338875, 0.02690742164850235, -0.046081095933914185, -0.01172757800668478, -0.17427881062030792, 0.1280810683965683, -0.020170705392956734, -0.05219827964901924, -0.09254913032054901, -0.12572002410888672, -0.031235501170158386, -0.11020348966121674, -0.04978787526488304, -0.006843593902885914, -0.020793767645955086, -0.028457343578338623, -0.008998717181384563, 0.05406098812818527, -0.27279388904571533, -0.009513987228274345, 0.018764406442642212, -0.0015718151116743684, -0.13131968677043915, 0.09142669290304184, 0.10351511090993881, -0.030419502407312393, -0.1432599276304245, -0.009287855587899685, -0.033508043736219406, -0.015276574529707432, -0.1266249567270279, 0.03986708074808121, 0.054200783371925354, -0.17977063357830048, -0.022821463644504547, 0.053381819278001785, 0.043274469673633575, 0.2654705345630646, 0.013083706609904766, -0.004246684722602367, -0.14177575707435608, 0.07541196048259735, -0.05418840050697327, -0.016888709738850594, -0.14089654386043549, 0.16275012493133545, 0.11220844835042953, -0.02288704551756382, 0.23726005852222443, -0.12572705745697021, 0.14999864995479584, -0.10585939139127731, -0.02205202914774418, 0.018930301070213318, 0.02686970680952072, 0.06209142133593559, 0.1104283258318901, 0.04461176320910454, 0.04391708970069885, 0.02502991259098053, -0.026682354509830475, 0.002544182352721691, -0.0156664177775383, 0.010572511702775955, 0.08917457610368729, -0.006856014486402273, -0.0009156588348560035, -0.017296331003308296, -0.0329497866332531, -0.030972590669989586, -0.07479522377252579, -1.0701341309425135e-32, 0.0053026401437819, 0.020855778828263283, 0.10810201615095139, -0.051167428493499756, -0.07716414332389832, -0.025924796238541603, -0.008352398872375488, 0.040715962648391724, 0.0492880642414093, -0.115931935608387, 0.06815049052238464, 0.08067978173494339, 0.0033336912747472525, -0.06472454220056534, 0.058747682720422745, 0.05932839214801788, -0.02836197428405285, -0.06035570427775383, 0.10938616096973419, -0.17192339897155762, -0.014945830218493938, 0.043381523340940475, -0.09245827794075012, 0.29914575815200806, 0.07118348032236099, 0.01731499284505844, -0.038020431995391846, 0.06504109501838684, 0.05548926070332527, -0.009895211085677147, -0.04383828863501549, 0.0735437273979187, 0.010519493371248245, 0.1811358630657196, -0.12351938337087631, 0.015810271725058556, -0.02200283482670784, -0.03797949478030205, 0.008250360377132893, -0.03828967362642288, 0.09242497384548187, -0.019376469776034355, -0.06217300146818161, 0.033536043018102646, 0.007398521993309259, 0.05453138425946236, 0.04124997928738594, -0.06316074728965759, 0.13902007043361664, 0.07019244879484177, 0.03284168988466263, 0.04735243320465088, -0.07060389220714569, 0.14219459891319275, 0.020682277157902718, 0.11517926305532455, 0.02428964525461197, 0.017443068325519562, -0.2064545601606369, -0.04454372450709343, 0.02227363921701908, 0.16267405450344086, -0.09634435176849365, 0.1097874790430069, 0.09683496505022049, 0.0912700816988945, -0.008219785988330841, -0.02831420488655567, -0.025751972571015358, -0.07571202516555786, 0.0029860306531190872, -0.08694838732481003, 0.008205810561776161, -0.1669968068599701, -0.1020813137292862, 0.17885464429855347, 0.03391215577721596, -0.13001206517219543, -0.18324747681617737, 0.07190746814012527, 0.038554493337869644, 0.023695826530456543, 0.053028468042612076, 0.07088034600019455, 0.02049097791314125, 0.07384534180164337, -0.012769738212227821, -0.006333230063319206, -0.03035711497068405, -0.030743271112442017, -0.06621970236301422, -0.26412370800971985, -0.21787148714065552, 0.05779500678181648, 0.10906800627708435, -9.981226156696721e-08, -0.022547801956534386, -0.11846935749053955, -0.0805242508649826, 0.11285162717103958, 0.055541206151247025, -0.032093342393636703, 0.0016842264449223876, 0.03547612950205803, 0.06434877961874008, 0.1568552553653717, 0.12167336046695709, 0.020322417840361595, -0.17246145009994507, -0.003509846981614828, -0.08688054978847504, -0.05484180524945259, -0.07098903506994247, 0.09970635920763016, 0.03565176948904991, -0.11301760375499725, -0.009476392529904842, 0.08374906331300735, 0.21305623650550842, -0.02507389709353447, -0.00125872902572155, -0.031567931175231934, -0.14879243075847626, 0.015642939135432243, 0.061061467975378036, 0.06305613368749619, 0.005952643230557442, -0.03236783295869827, 0.060258105397224426, -0.01861564628779888, 0.0202914047986269, -0.1043255552649498, -0.04259549453854561, 0.0654458999633789, -0.031126806512475014, 0.05464666709303856, -0.1002265140414238, -0.062052637338638306, -0.10017180442810059, -0.00016016361769288778, 0.02685961127281189, -0.04229244962334633, -0.05286449193954468, 0.05524393543601036, 0.12923359870910645, -0.20110900700092316, 0.13950207829475403, -0.07291309535503387, 0.164406418800354, 0.04240158200263977, -0.020377082750201225, 0.2495952695608139, -0.19169145822525024, -0.06909056752920151, -0.1047135517001152, 0.00503671495243907, 0.08982700109481812, -0.2121102213859558, -0.0038907777052372694, 0.09062080830335617], "changes": {"1wk": 0.5063286249386676, "1mo": -20.506327417756005}}, {"text": "Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? Laiba Immad Wed, Dec 4, 2024, 9:02 PM 6 min read In This Article: ETNB -3.23% We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds . In this article, we are going to take a look at where 89bio, Inc. (NASDAQ:ETNB) stands against the other small-cap biotech stocks. Revolutionizing Healthcare and Economy: The Rapid Growth of Biotechnology The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance. Advances in fields like gene editing, sequencing, personalized medicine, and artificial intelligence are making new techniques possible, while the aging population and growing healthcare demands are driving a robust market for new treatments. According to a report by McKinsey & Company, venture capital firms made approximately $52 billion in global investments in therapeutic-focused biotech companies between 2019 and 2021. Two-thirds of this sum was given to platform-tech start-up companies. Despite its growth, many biotech companies have faced challenges in turbulent markets, taking drastic measures such as cutting programs and implementing significant layoffs to conserve cash. While recent rate cuts could encourage the revival of scientific projects, analysts like Jared Holz note the difficulty of gauging their impact. Holz also highlighted a shift in market dynamics, observing that biotech's performance increasingly correlates with small-cap equities. If small-cap stocks trade well, biotech is likely to follow, though stagnation could occur if momentum fades. Notably, the idea of interest rates predicting biotech success is relatively new, emerging only after the pandemic, which reshaped the industry by driving substantial investment into therapeutic-focused companies. With innovative treatments, biotech businesses are revolutionizing healthcare by tackling important unmet medical needs. Establishing the National Bioeconomy Board as a component of Biden's Investing in America agenda is a significant breakthrough. It seeks to maximize biotechnology's economic potential in the United States. Furthermore, policy suggestions to expedite the approval process for biotechnology goods are being developed by the National Security Commission on Emerging Biotechnology. More academics will be able to use biotechnology for agricultural purposes if entry obstacles are reduced, which will benefit American farmers and increase food security. It is anticipated that these initiatives will open up new markets. Pharmaceuticals as Defensive Investments and the 2024 Healthcare Market Outlook This year (2024) started strongly for the biotechnology sector due to a rise in mergers and acquisitions as well as anticipations of falling interest rates. Therefore, estimates suggest that the worldwide biotechnology market might increase at a compound annual growth rate (CAGR) of around 14% from 2024 to 2033, reaching an astonishing $5.7 trillion. The market for agricultural biotechnology is also expected to develop at a 7.9% compound annual growth rate (CAGR) and reach $232 billion by 2032. Story Continues But even with the market's potential, investing in biotech companies still carries a number of serious dangers. Bankruptcy may result from failing to satisfy clinical trial endpoints or obtain adequate finance before a product launch. In the biotech industry, where drug development usually takes more than ten years and has an estimated failure rate of about 90%, the danger of failure is very substantial. Hence, biotech stocks are often considered \u201chigh-risk, high-reward\u201d investments due to their upside potential coupled with significant risks Our Methodology In our methodology, we identified the top small-cap biotech stocks with significant growth potential, ranked according to their total hedge fund holdings as of Q2 2024. Our selection process began by filtering companies with a small market capitalization. Next, we reviewed analyst recommendations, focusing on stocks with strong bullish sentiment and high institutional ownership. Finally, we ranked these companies based on the number of hedge funds holding their shares as of Q2 2024. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ( see more details here ). A scientist in a lab coat researching data and researching new therapies. 89bio, Inc. (NASDAQ: ETNB ) Number of Hedge Fund Holdings: 30 89bio, Inc. (NASDAQ:ETNB) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for liver and cardio-metabolic diseases. The company stands out with its focus on FGF21 analogs, especially BIO89-100, which has shown strong potential in clinical trials for NASH, demonstrating safety and significant reductions in liver fat and lipid markers. With a dual focus on NASH and SHTG, the company targets two large markets with one lead candidate. Its innovative use of glycoPEGylation technology enhances BIO89-100's efficacy and durability, positioning the company competitively in the biotech field. As of September 30, 2024, 89bio, Inc. (NASDAQ:ETNB) reported $423.8 million in cash, cash equivalents, and marketable securities, ensuring robust funding for its clinical trials and operations. In Q3 2024, R&D expenses rose to $141.4 million (from $31.4 million in Q3 2023) due to an $81 million milestone payment to BiBo Biopharma, increased clinical and manufacturing costs, and higher personnel expenses. G&A expenses also increased to $10.5 million from $7.9 million. The net loss for Q3 2024 widened to $149.1 million, reflecting the company's investments in clinical progress, including pivotal Phase 3 trials for its lead candidate, pegozafermin, targeting MASH and SHTG. These trials aim to address significant unmet medical needs, with potential for accelerated approvals in the U.S. and Europe. Additionally, an amended credit facility with K2 HealthVentures provides access to up to $150 million, supporting 89bio, Inc. (NASDAQ:ETNB)'s growth. As of Q3 2024, 30 hedge funds tracked by Insider Monkey held stakes in the stock, with RA Capital Management being the largest shareholder, holding $104.8 million in shares. Analysts have a Moderate Buy rating on the stock, with an average 12-month price target of $27.00, ranging from $12.00 to $34.00. This suggests a potential upside of 224.91% from the stock's current price of $8.31. ETNB ranks fifth on our list of the best biotech stocks. Overall ETNB ranks 7th on our list of the best small-cap biotech stocks with massive potential according to hedge funds. While we acknowledge the potential of ETNB as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ETNB but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock Disclosure: None. This article is originally published at Insider Monkey . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2024-12-04T18:02:08+00:00", "sentiment": {"score": 0.7752774506807327, "confidence": 0.7917308211326599, "probabilities": {"positive": 0.7917308211326599, "negative": 0.016453370451927185, "neutral": 0.1918158084154129}}, "embedding": [0.059608057141304016, -0.14277368783950806, 0.014958800747990608, -0.06436284631490707, 0.12291823327541351, 0.034091200679540634, -0.0289393812417984, 0.13393929600715637, 0.10876847803592682, 0.09466582536697388, -0.12462269514799118, 0.09609606862068176, -0.058685388416051865, 0.0030486788600683212, -0.12072120606899261, -0.013122303411364555, -0.08358342945575714, 0.0037796897813677788, -0.12457729130983353, 0.10906624048948288, -0.015838831663131714, 0.03511735051870346, 0.04462290555238724, 0.017220616340637207, -0.0030265990644693375, -0.04322223365306854, -0.03484597057104111, -0.10102993249893188, -0.26906824111938477, -0.01805121637880802, 0.09916450083255768, 0.14062601327896118, 0.060891397297382355, -0.03942233324050903, 0.022822115570306778, 0.061531003564596176, -0.10035818815231323, 0.11251746118068695, 0.09665912389755249, -0.03066962957382202, 0.0279240719974041, -0.09862149506807327, -0.08852903544902802, 0.08973957598209381, 0.12162275612354279, -0.12557658553123474, -0.013675129041075706, -0.0610232912003994, 0.06048642843961716, -0.05187608301639557, -0.19566699862480164, -0.17734703421592712, 0.021834149956703186, -0.051849909126758575, -0.005121428985148668, -0.058722857385873795, -0.05816168338060379, -0.08918386697769165, 0.01684970036149025, 0.050680048763751984, 0.1017351746559143, -0.11662115901708603, 0.10366465151309967, -0.033603910356760025, 0.0894307792186737, -0.07524412870407104, 0.09887661039829254, 0.10195678472518921, -0.07067577540874481, 0.05712595954537392, 0.1317666620016098, -0.0804581344127655, -0.1122642531991005, 0.11565536260604858, -0.06775209307670593, 0.11792714893817902, 0.10240022093057632, 0.256266713142395, 0.2014620304107666, -0.06420323252677917, 0.036153458058834076, -0.08804897218942642, 0.009305346757173538, -0.043791476637125015, -0.16542182862758636, 0.008835677057504654, 0.06040350720286369, 0.07106737792491913, 0.06299056112766266, 0.03511451929807663, -0.0088935736566782, -0.031501077115535736, 0.08441655337810516, 0.034602437168359756, 0.1046898290514946, -0.061228685081005096, -0.09642826020717621, -0.034670352935791016, 0.05513036996126175, 0.007271269802004099, 0.05342898517847061, 0.002029496245086193, -0.053484730422496796, 0.027960754930973053, -0.05469232425093651, -0.07809017598628998, 0.0032548103481531143, -0.07294004410505295, 0.14382630586624146, 0.10481676459312439, -0.08568114042282104, 0.12195747345685959, -0.10477166622877121, 0.08855807781219482, -0.10953523963689804, 0.13149774074554443, -0.004370781593024731, -0.04436979442834854, 0.13580404222011566, 0.05485106632113457, 0.020145438611507416, 0.07714678347110748, -0.06500452011823654, -0.1669314056634903, -0.11579303443431854, 0.08472266793251038, -0.17437732219696045, 8.812916246984854e-33, -0.03994607925415039, 0.039831437170505524, 0.0029486524872481823, 0.01144115999341011, -0.05315931886434555, -0.016164328902959824, -0.008354772813618183, -0.05002419650554657, -0.16768985986709595, -0.07101373374462128, -0.1738850474357605, 0.07411366701126099, -0.018937580287456512, 0.10744999349117279, 0.0007291324436664581, -0.19266875088214874, -0.035975124686956406, 0.06339384615421295, 0.027000486850738525, -0.058493174612522125, -0.12375486642122269, -0.012146945111453533, -0.057697828859090805, 0.04183126986026764, 0.027683040127158165, -0.1466282308101654, -0.08545070886611938, -0.034305207431316376, 0.08755934238433838, 0.06517478823661804, -0.12078022211790085, 0.08656736463308334, -0.04535882920026779, -0.08806008100509644, -0.026834765449166298, -0.1143462210893631, -0.0452691912651062, -0.09175769239664078, 0.09502041339874268, 0.13312536478042603, -0.08781096339225769, 0.13677693903446198, -0.11083440482616425, -0.042447250336408615, 0.042647555470466614, 0.07121410965919495, 0.0032776310108602047, 0.06866009533405304, -0.07288101315498352, 0.01598498784005642, -0.09807838499546051, 0.10376421362161636, 0.06595801562070847, -0.0939292311668396, 0.05255943164229393, -0.0290977843105793, -0.19800585508346558, -0.10917355865240097, -0.009848298504948616, -0.0033729318529367447, -0.012982573360204697, 0.07743355631828308, -0.020788153633475304, 0.12183811515569687, -0.10462932288646698, 0.23300912976264954, 0.11513996124267578, 0.11240755021572113, -0.10200893878936768, 0.23413574695587158, 0.0659206360578537, -0.09874803572893143, -0.014973272569477558, -0.05885571613907814, 0.012102271430194378, -0.042738769203424454, -0.056497618556022644, 0.07238704711198807, -0.034943174570798874, 0.08001051098108292, 0.06909727305173874, 0.03378170356154442, -0.17329350113868713, 0.02156369388103485, -0.0003819689154624939, 0.011218386702239513, 0.0017756053712219, 0.12119486927986145, 0.0054426779970526695, -0.017168693244457245, -0.07490143924951553, -0.05430997163057327, -0.007952886633574963, 0.170984148979187, -0.01854144223034382, -1.054639866435928e-32, -0.010926642455160618, -0.08908793330192566, 0.0033587412908673286, 0.040743388235569, -0.004703812301158905, 0.015944939106702805, 0.06642194092273712, -0.1368226855993271, 0.025439584627747536, -0.07450040429830551, 0.00014898739755153656, 0.06595061719417572, 0.04383087158203125, -0.022117599844932556, -0.14132648706436157, -0.008620213717222214, -0.04101206734776497, -0.0837210938334465, 0.0330839529633522, -0.02642448991537094, 0.05773138254880905, 0.05376896262168884, -0.12005359679460526, 0.07557946443557739, 0.001802066690288484, 0.08551637828350067, -0.1086452305316925, 0.15392830967903137, 0.029364682734012604, -0.09601052105426788, -0.09961000084877014, 0.044744569808244705, -0.21135756373405457, 0.1364213079214096, -0.08697140216827393, 0.09040650725364685, 0.03359580039978027, -0.16703537106513977, 0.08520530164241791, -0.02671641670167446, 0.09449498355388641, -0.012974508106708527, -0.10473484545946121, 0.023553667590022087, 0.0032533288467675447, -0.04771285131573677, -0.021127849817276, 0.08729906380176544, 0.16005133092403412, -0.0030495598912239075, -0.003702830523252487, 0.11925780773162842, 0.08435393124818802, -0.029206445440649986, -0.14750662446022034, 0.023534558713436127, 0.051556505262851715, 0.027948683127760887, -0.09614486992359161, 0.05376238003373146, 0.025934766978025436, 0.05461849644780159, 0.03574180603027344, 0.05048855394124985, -0.0959833636879921, -0.021259989589452744, 0.11222469061613083, 0.03324328362941742, -0.07337091863155365, -0.12441395223140717, 0.07044009119272232, -0.03133521229028702, 0.037702254951000214, -0.0509842187166214, -0.04512770101428032, 0.2260865569114685, -0.026035912334918976, -0.13432364165782928, -0.11886104941368103, 0.06954919546842575, 0.07810300588607788, -0.004085306078195572, 0.06434760987758636, -0.05567236989736557, -0.022190701216459274, 0.11687390506267548, -0.035332705825567245, -0.04426046460866928, -0.11594203114509583, 0.0006882864981889725, -0.14367741346359253, -0.20870372653007507, -0.026247937232255936, 0.10681759566068649, -0.05680176988244057, -1.005158338784895e-07, 0.185562402009964, -0.14722982048988342, 0.08009575307369232, -0.1134546622633934, 0.0723862275481224, -0.038337044417858124, -0.12575869262218475, 0.11440165340900421, 0.11934281885623932, 0.16576513648033142, 0.046641670167446136, 0.18963059782981873, -0.16267603635787964, 0.20681782066822052, -0.04249727353453636, 0.07128313928842545, -0.14986559748649597, 0.03077462688088417, -0.017615551128983498, -0.01624254323542118, -0.03096786141395569, 0.11500734835863113, 0.016704171895980835, 0.0021547460928559303, 0.040929172188043594, -0.08945398032665253, 0.015599578619003296, 0.030829116702079773, -0.02305776998400688, 0.01641051471233368, -0.00533739197999239, -0.0596153549849987, 0.033397406339645386, 0.056004248559474945, -0.05223172530531883, -0.07329034805297852, 0.04364817216992378, 0.005854612682014704, 0.004523548297584057, 0.020382411777973175, 0.005166483577340841, -0.008302387781441212, -0.0699373334646225, -0.05802445858716965, -0.056213364005088806, -0.13550809025764465, -0.10102543234825134, 0.11755664646625519, 0.07662118971347809, -0.15680256485939026, 0.07280133664608002, 0.023496801033616066, 0.024973459541797638, 0.03736761584877968, 0.002457335591316223, 0.15130168199539185, -0.10162912309169769, -0.02471914142370224, -0.07009716331958771, -0.02440011501312256, 0.005540087819099426, -0.26818493008613586, 0.12722058594226837, -0.0030827224254608154], "changes": {"1wk": -3.132532806108479, "1mo": -4.09638728644159}}, {"text": "89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants 89bio, Inc. Wed, Nov 13, 2024, 7:58 AM 5 min read In This Article: ETNB -3.23% 89bio, Inc. SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (\u201c89bio\u201d) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the pricing of its previously announced upsized underwritten public offering of 11,455,882 shares of its common stock at a public offering price per share of $8.50 and, in lieu of common stock to a certain investor, pre-funded warrants to purchase up to 3,250,000 shares of its common stock at a public offering price of $8.499. The pre-funded warrants have an exercise price of $0.001 per share and are exercisable immediately. In addition, 89bio has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 2,205,882 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds of the offering to 89bio, before deducting the underwriting discounts and commissions and other offering expenses payable by 89bio, are expected to be approximately $125.0 million. The offering is expected to close on or about November 14, 2024, subject to the satisfaction of customary closing conditions. Goldman Sachs & Co. LLC, Leerink Partners and Evercore ISI are acting as book-running managers for the offering. An automatically effective shelf registration statement relating to these securities was filed with the Securities and Exchange Commission (\u201cSEC\u201d) on May 23, 2023. The offering of the securities is being made only by means of a prospectus, including a prospectus supplement, forming a part of an effective registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC\u2019s website, located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus related to the offering will be filed with the SEC and will be available on the SEC\u2019s website at www.sec.gov and may also be obtained, when available, by contacting: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526 or by email at prospectus-ny@ny.email.gs.com; Leerink Partners, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at (800) 808-7525, ext. 6105, or by email at syndicate@leerink.com ; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, New York 10055, by telephone at (888) 474-0200 or by email at ecm.prospectus@evercore.com. Story Continues This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is in Phase 3 clinical trials for its lead candidate, pegozafermin, for the treatment of metabolic dysfunction-associated steatohepatitis and severe hypertriglyceridemia. Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco. Forward-Looking Statements Certain statements in this press release may constitute \u201cforward-looking statements\u201d within the meaning of the federal securities laws, including, but not limited to, 89bio\u2019s expectations regarding the consummation of the offering and the satisfaction of customary closing conditions with respect to the offering. Words such as \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cobjective,\u201d \u201cintend,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201ccan,\u201d \u201cwould,\u201d \u201cexpect,\u201d \u201cbelieve,\u201d \u201cdesign,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cpotential,\u201d \u201canticipate,\u201d \u201cgoal,\u201d \u201copportunity,\u201d \u201cdevelop,\u201d \u201cplan\u201d or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements. While 89bio believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in 89bio\u2019s filings with the SEC), many of which are beyond 89bio\u2019s control and subject to change. Actual results could be materially different. Risks and uncertainties include: changes as a result of market conditions or for other reasons; the risk that the offering will not be consummated; the impact of general economic, health, industrial or political conditions in the United States or internationally; and other risks and uncertainties identified in 89bio\u2019s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and other subsequent disclosure documents filed with the SEC. 89bio claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. 89bio expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. Investor Contact: Annie Chang 89bio, Inc. annie.chang@89bio.com PJ Kelleher LifeSci Advisors, LLC +1 617-430-7579 pkelleher@lifesciadvisors.com Media Contact: Sheryl Seapy Real Chemistry sseapy@realchemistry.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ETNB", "date": "2024-11-13T04:58:00+00:00", "sentiment": {"score": 0.005705036222934723, "confidence": 0.025448497384786606, "probabilities": {"positive": 0.025448497384786606, "negative": 0.019743461161851883, "neutral": 0.9548079967498779}}, "embedding": [-0.11891195923089981, -0.04814084619283676, -0.031063254922628403, 0.030261993408203125, -0.06538417935371399, 0.06458491832017899, 0.005119494162499905, 0.24376358091831207, 0.1369181126356125, 0.06374114006757736, 0.01602199673652649, -0.038336023688316345, 0.02291513979434967, -0.08394527435302734, -0.03824031352996826, -0.11487704515457153, 0.012444362044334412, -0.04355792701244354, -0.1933886557817459, 0.150089293718338, -0.020940739661455154, 0.02206999808549881, -0.0365457609295845, -0.051256611943244934, 0.0038485312834382057, -0.09269939363002777, 0.04546467214822769, -0.03855850547552109, -0.16126799583435059, -0.04986434429883957, 0.09821581095457077, 0.024046272039413452, 0.11276990175247192, -0.02621116116642952, 0.04649173468351364, -0.07448206096887589, -0.12043626606464386, 0.06098032742738724, -0.0010780571028590202, -0.008713395334780216, -0.05775507539510727, -0.020653553307056427, -0.17106232047080994, 0.17472532391548157, 0.07714490592479706, -0.09187090396881104, -0.054204680025577545, 0.1360739767551422, 0.07943817973136902, 0.030606096610426903, -0.10890372097492218, -0.1377716362476349, -0.03027678094804287, 0.04342755302786827, -0.06540367007255554, -0.11294856667518616, -0.17904654145240784, -0.13693077862262726, 0.030563872307538986, -0.005467001348733902, 0.06016130745410919, -0.041608698666095734, -0.019488636404275894, 0.023234590888023376, 0.09793005138635635, 0.020403824746608734, 0.1466047763824463, -0.06402011960744858, 0.029753070324659348, 0.0205296128988266, 0.22133320569992065, 0.01474276278167963, -0.07762347161769867, 0.12354767322540283, -0.13869106769561768, 0.14339809119701385, 0.08453892171382904, 0.061389245092868805, 0.056516095995903015, -0.1391156017780304, 0.002755130175501108, 0.005386088974773884, -0.009511451236903667, -0.1319006085395813, 0.018293660134077072, -0.07403718680143356, 0.00773341441527009, 0.17859041690826416, 0.11648622155189514, 0.014044520445168018, 0.10860365629196167, -0.06010918691754341, 0.012229210697114468, -0.11211546510457993, -0.03947988897562027, -0.021058088168501854, -0.12443779408931732, 0.018854374065995216, 0.014203448779881, 0.0785394161939621, 0.0800183117389679, 0.05965631082653999, -0.11278610676527023, -0.018060175701975822, -0.06287233531475067, -0.08270598948001862, 0.06608672440052032, 0.03613610565662384, 0.008840585127472878, 0.03930388763546944, -0.17702585458755493, 0.004713024012744427, -0.11030058562755585, -0.022468389943242073, -0.12984970211982727, 0.12884438037872314, 0.07013078033924103, 0.011484308168292046, 0.1881098747253418, -0.04183683171868324, 0.06324104964733124, 0.0818372368812561, 0.046100761741399765, -0.11206383258104324, -0.09414566308259964, -0.13768619298934937, -0.13410772383213043, 5.7026228468983764e-33, -0.09113697707653046, -0.04746384918689728, -0.06978312879800797, -0.08926668018102646, -0.01465788297355175, 0.05116552114486694, 0.025897366926074028, 0.03624127060174942, -0.16953924298286438, 0.11051644384860992, -0.14884549379348755, 0.11125154048204422, 0.018436966463923454, 0.07172134518623352, -0.08251393586397171, -0.07994616776704788, 0.006184492260217667, 0.09473591297864914, 0.12425317615270615, 0.005187703296542168, 0.051917530596256256, 0.010929413139820099, -0.022102609276771545, 0.055098384618759155, -0.043639324605464935, 0.05908546596765518, -0.012365110218524933, -0.00589987076818943, 0.04655572026968002, 0.0174519345164299, -0.01573018729686737, -0.0009001325815916061, -0.03691989183425903, -0.10223354399204254, 0.0008510053157806396, -0.023320820182561874, 0.03461911156773567, -0.050001271069049835, 0.12091715633869171, 0.04621434956789017, -0.01952383853495121, 0.14706245064735413, -0.06409766525030136, -0.12288796901702881, 0.01059439405798912, -0.004137903917580843, -0.06828623265028, 0.04575129598379135, 0.048162318766117096, 0.0076706185936927795, -0.07501748204231262, 0.006702659651637077, -0.06468115746974945, 0.01089354045689106, -0.10926248133182526, -0.09771603345870972, -0.11551901698112488, 0.030923977494239807, 0.024779673665761948, 0.07320462167263031, 0.1269170492887497, 0.17968183755874634, -0.07972471415996552, 0.06618373095989227, -0.2826201021671295, 0.11381463706493378, -0.08663733303546906, -0.010981249623000622, -0.09590473771095276, 0.10520756244659424, 0.008122595027089119, -0.06908868253231049, 0.07747893780469894, -0.10423021018505096, 0.0038028648123145103, -0.06396833062171936, 0.03344659507274628, 0.05316804349422455, 0.13105085492134094, 0.07708223164081573, -0.006141750607639551, -0.050012946128845215, -0.0027523660100996494, 0.13083116710186005, 0.011757703498005867, 0.04253401607275009, -0.019955959171056747, 0.07014203816652298, -0.0941547304391861, -0.030194949358701706, 0.13426756858825684, 0.057872362434864044, -0.12596887350082397, 0.1222192645072937, 0.11364246904850006, -6.689659739344927e-33, -0.05735210329294205, -0.0208921916782856, -0.03774349018931389, -0.01570190116763115, -0.04807152599096298, 0.14557838439941406, 0.031218495219945908, -0.06174838915467262, 0.013157028704881668, -0.09472070634365082, -0.09204985946416855, 0.07599084824323654, 0.03535155951976776, -0.06518790125846863, -0.03750421851873398, -0.05523921176791191, -0.046006157994270325, 0.05040666460990906, 0.08476610481739044, 0.00030452385544776917, -0.10072613507509232, 0.18762068450450897, 0.035422056913375854, 0.04646066948771477, 0.031600192189216614, 0.05120173096656799, 0.0583648607134819, 0.18321847915649414, -0.006827807053923607, 0.041149288415908813, -0.02356196567416191, -0.07433971762657166, -0.21121716499328613, 0.12699680030345917, -0.1658179759979248, -0.023402005434036255, 0.13345202803611755, -0.017314571887254715, 0.07326459139585495, 0.050736188888549805, 0.08947335183620453, 0.03548711910843849, 0.07860693335533142, 0.06201242282986641, 0.03415738046169281, -0.06803787499666214, 0.04964512959122658, -0.1479986608028412, 0.16216599941253662, 0.030192233622074127, 0.014676314778625965, -0.0027790041640400887, 0.03781877085566521, 0.12435382604598999, -0.12008235603570938, 0.06438342481851578, -0.03400286287069321, 0.0012146462686359882, 0.08376406133174896, 0.0005112653598189354, 0.08925089240074158, 0.21681725978851318, 0.0019513871520757675, -0.009735722094774246, 0.12863580882549286, 0.03289301320910454, 0.05087263882160187, -0.02833658829331398, -0.02391262724995613, -0.13977012038230896, -0.03587520867586136, -0.2459983378648758, -0.0759304016828537, -0.1520392894744873, 0.012398399412631989, 0.20643875002861023, 0.029818855226039886, -0.09867075085639954, -0.0033331885933876038, 0.028611648827791214, 0.0035007596015930176, 0.019440338015556335, -0.0028634993359446526, 0.08113031834363937, -0.038881730288267136, -0.020200859755277634, 0.05605240911245346, 0.08299894630908966, -0.04443848505616188, 0.17641881108283997, -0.05585278570652008, -0.057225242257118225, 0.08371241390705109, 0.018252328038215637, -0.06416261196136475, -1.0018663942901185e-07, 0.040203291922807693, -0.0499536469578743, 0.06674090027809143, -0.039654165506362915, 0.1240432858467102, -0.10709211230278015, 0.0341590940952301, -0.010244682431221008, -0.018337104469537735, 0.047618210315704346, 0.16286525130271912, 0.08708837628364563, -0.16616132855415344, 0.06392816454172134, -0.1187092736363411, -0.05612286925315857, -0.11994054913520813, 0.05914873629808426, -0.0801602154970169, 0.00352726923301816, -0.09488570690155029, 0.08584067225456238, 0.10804470628499985, -0.07827350497245789, -0.027507510036230087, -0.020487619563937187, -0.003073467407375574, 0.07799572497606277, 0.012535307556390762, 0.04752523824572563, -0.033939775079488754, 0.01491263136267662, 0.042331188917160034, 0.04240692779421806, -0.053350504487752914, -0.10299238562583923, -0.04399494081735611, 0.09519687294960022, 0.0045200493186712265, 0.0836467370390892, -0.07791079580783844, -0.09065867960453033, -0.05465533211827278, 0.05684608966112137, 0.15427735447883606, -0.07303273677825928, -0.2759082317352295, 0.005389673635363579, 0.011704482138156891, -0.20828299224376678, 0.051339298486709595, 0.0428638681769371, -0.03678800165653229, 0.07862277328968048, -0.09826430678367615, 0.05289477854967117, -0.11631251126527786, 0.03617188334465027, -0.035947948694229126, 0.04999956116080284, 0.06248043477535248, -0.3064255714416504, -0.04652318358421326, -0.014197370037436485], "changes": {"1wk": -10.375773356061769, "1mo": -11.946158853365754}}, {"text": "89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting\u00ae 2024 89bio, Inc. Fri, Nov 15, 2024, 4:05 PM 7 min read In This Article: ETNB -3.23% 89bio, Inc. New post-hoc analyses reinforce pegozafermin\u2019s potential anti-fibrotic effects and the potential utility of non-invasive tests which correlate to histological endpoints SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- \u00a089bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, announced new analyses of data from the Phase 2b ENLIVEN trial evaluating pegozafermin in metabolic dysfunction-associated steatohepatitis (MASH) patients with advanced fibrosis. The findings were presented in four poster sessions at The American Association for the Study of Liver Diseases (AASLD) The Liver Meeting \u00ae being held in San Diego, California. \"We are excited to present additional analyses from our Phase 2b ENLIVEN trial at this year\u2019s Liver Meeting, which reinforce pegozafermin's potential effectiveness in reversing fibrosis and preventing progression to cirrhosis in patients with advanced MASH,\" said Hank Mansbach, Chief Medical Officer of 89bio. \"These analyses strengthen our confidence in the design of our Phase 3 trials for both cirrhotic and non-cirrhotic MASH, and we look forward to building on this momentum as we advance these trials.\" \u201cMASH is often underdiagnosed and undertreated, which can lead to cirrhosis and severe complications like the need for liver transplantation,\u201d said Naim Alkhouri, MD, Chief Medical Officer, Chief of Transplant Hepatology, and Director of the Fatty Liver Program at Arizona Liver Health (ALH). \u201cThese post-hoc analyses demonstrate the potential of NITs like FAST and AGILE3+ to identify high-risk patients more conveniently, potentially reducing the need for liver biopsy. The results show that pegozafermin not only improved patients\u2019 FAST scores but also achieved both MASH resolution and fibrosis improvement, indicating its potential as a treatment option for patients with advanced MASH.\u201d Publications Presented at the Meeting: Pegozafermin reduced progression to cirrhosis: A post-hoc analysis from the Phase 2b ENLIVEN study (Publication 1563). Biomarker response in metabolic dysfunction-associated steatohepatitis (MASH) patients with high-risk baseline FAST scores: Observations from the ENLIVEN Phase 2b trial with pegozafermin (Publication 1549). Diagnostic potential of FAST and AGILE3+ scores for F2/F3 fibrosis: An analysis of the Phase 2 ENLIVEN study (Publication 2014). Analysis and integration of machine learning for biomarker assessments and their association with treatment response: Insights from the ENLIVEN Phase 2b trial of pegozafermin (Publication 2008) Story continues A copy of the AASLD posters will be accessible under \u201cScientific Publications\u201d in the pipeline section of 89bio's website . About ENLIVEN ENLIVEN was a multicenter, randomized, double-blind, placebo-controlled Phase 2b trial designed to evaluate the safety and efficacy of weekly or every-two-week dosing of pegozafermin for the treatment of patients with biopsy confirmed MASH and NAS \u2265 4 for 48 weeks. In the trial, 192 patients were dosed with pegozafermin 15mg QW, 30mg QW and 44mg Q2W, or placebo. Primary outcomes measured were proportion of participants with resolution of MASH without worsening of fibrosis and proportion of participants with \u22651 stage decrease in fibrosis stage with no worsening of MASH at week 24. Secondary measures included change from baseline in liver fat, liver enzymes, noninvasive markers of liver fibrosis, glycemic control, lipoproteins, and body weight as well as safety and tolerability measures. Patients who entered the blinded extension phase were subsequently treated for an additional 24 weeks for a total treatment period of 48 weeks. Some patients who were on placebo (n=19) were re-randomized to receive pegozafermin in the extension phase. Key endpoints in the extension phase include liver fat and noninvasive markers of liver fibrosis and inflammation. ENLIVEN achieved high statistical significance on primary histology endpoints with 30mg QW and 44mg Q2W dosing at week 24 and the results were published in the New England Journal of Medicine. To learn more about the clinical trial, visit clinicaltrials.gov: NCT04929483. About pegozafermin Pegozafermin is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21) being developed for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). FGF21 is an endogenous hormone that has broad effects such as regulating energy expenditure, glucose and lipid metabolism. In clinical trials, pegozafermin has demonstrated direct anti-fibrotic and anti-inflammatory effects on the liver, as well as reduced triglyceride levels, improved insulin resistance and glycemic control, and continued to demonstrate a favorable safety and tolerability profile. Pegozafermin received Breakthrough Therapy designation (BTD) status from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) status from the European Medicines Agency (EMA) for the treatment of MASH with fibrosis. Pegozafermin is being studied in the Phase 3 ENLIGHTEN trial program for MASH and the Phase 3 ENTRUST trial for SHTG. About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on rapidly advancing its lead candidate, pegozafermin, through clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 (FGF21) analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco. For more information, visit www.89bio.com or follow the company on LinkedIn . Forward-Looking Statements Certain statements in this press release may constitute \"forward-looking statements\" within the meaning of the federal securities laws, including, but not limited to, statements regarding the therapeutic potential and utility, efficacy and clinical benefits of pegozafermin, the safety and tolerability profile of pegozafermin and trial designs, clinical development plans and timing for pegozafermin, including confirming the long-term efficacy, tolerability and sustained improvement in key liver health markers observed in the Phase 2b ENLIVEN trial evaluating pegozafermin in the current Phase 3 trials for both cirrhotic and non-cirrhotic MASH. Words such as \"may,\" \"might,\" \"will,\" \"objective,\" \"intend,\" \"should,\" \"could,\" \"can,\" \"would,\" \"expect,\" \"believe,\" \"design,\" \"estimate,\" \"predict,\" \"potential,\" \"anticipate,\" \"goal,\" \"opportunity,\" \"develop,\" \"plan\" or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While 89bio believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in 89bio's filings with the Securities and Exchange Commission (SEC)), many of which are beyond 89bio's control and subject to change. Actual results could be materially different. Risks and uncertainties include: expectations regarding the design of the ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis trials; expectations regarding the timing and outcome of the ENTRUST Phase 3 trial in SHTG; 89bio's ability to execute on its strategy; positive results from a clinical study may not necessarily be predictive of the results of future or ongoing clinical studies; receipt of BTD for pegozafermin in MASH may not result in a faster development process, review or approval compared to drugs considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA; 89bio's substantial dependence on the success of its lead product candidate; competition from competing products; the impact of general economic, health, industrial or political conditions in the United States or internationally; the sufficiency of 89bio's capital resources and its ability to raise additional capital; and other risks and uncertainties identified in 89bio\u2019s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and other subsequent disclosure documents filed with the SEC. 89bio claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. 89bio expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. Investor Contacts: Annie Chang 89bio, Inc. investors@89bio.com PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 pkelleher@lifesciadvisors.com Media Contact: Sheryl Seapy Real Chemistry sseapy@realchemistry.com View comments Terms and Privacy Policy Privacy Dashboard Recommended stories", "symbol": "ETNB", "date": "2024-11-15T13:05:00+00:00", "sentiment": {"score": 0.8844927186146379, "confidence": 0.8936620354652405, "probabilities": {"positive": 0.8936620354652405, "negative": 0.009169316850602627, "neutral": 0.09716872870922089}}, "embedding": [-0.03222879767417908, -0.18877136707305908, 0.0063829622231423855, -0.00579090928658843, -0.0416199266910553, -0.09237252175807953, -0.21587389707565308, 0.2848508358001709, -0.05946851521730423, 0.008485168218612671, -0.1065976470708847, -0.002870450261980295, 0.014925242401659489, 0.032044507563114166, 0.013990449719130993, -0.07944409549236298, 0.14588823914527893, 0.030927499756217003, 0.010837659239768982, 0.01411534659564495, -0.017028555274009705, -0.10340490192174911, 0.0675024688243866, -0.03996380418539047, -0.036418963223695755, 0.05150296911597252, -0.13239750266075134, 0.07783499360084534, -0.1557411104440689, -0.029199853539466858, 0.08191679418087006, 0.18232440948486328, 0.09330431371927261, -0.07281237840652466, -0.06149591505527496, -0.07083018869161606, -0.046135760843753815, 0.176651269197464, -0.11956359446048737, -0.19349144399166107, -0.05432938039302826, 0.05207373574376106, -0.0021331196185201406, 0.007902298122644424, 0.10387974977493286, -0.2553872764110565, -0.07934316247701645, 0.15673309564590454, -0.0274191927164793, 0.17424790561199188, -0.17962786555290222, -0.14194256067276, 0.046058520674705505, 0.22585520148277283, 0.11417019367218018, 0.03289124369621277, -0.015172235667705536, -0.062444016337394714, -0.03399644047021866, -0.07496365904808044, -0.19114775955677032, -0.047811247408390045, -0.00967836007475853, -0.15304341912269592, 0.20288807153701782, 0.04350370541214943, -0.01818254217505455, -0.16294056177139282, -0.0047323270700871944, 0.07408570498228073, 0.0450587272644043, -0.14995503425598145, 0.031502965837717056, 0.13204658031463623, -0.03825579956173897, 0.12285683304071426, -0.013532434590160847, 0.062407903373241425, 0.05905380845069885, 0.008060721680521965, 0.09571292251348495, 0.10562505573034286, 0.12444885075092316, -0.06849668174982071, -0.047640781849622726, 0.005235983524471521, -0.12970517575740814, 0.11048000305891037, -0.10295222699642181, 0.04467923566699028, 0.0926831066608429, 0.041778139770030975, 0.03365232050418854, 0.011755935847759247, 0.10633417963981628, -0.026280879974365234, -0.162931889295578, -0.004011666402220726, 0.006414934992790222, -0.04709026217460632, 0.089166060090065, 0.09722621738910675, -0.11004959046840668, -0.11584173887968063, -0.03256664052605629, -0.0064949048683047295, 0.10501882433891296, -0.0004071742296218872, 0.014145942404866219, 0.03969760239124298, 0.12254743278026581, 0.038148097693920135, 0.03388072922825813, -0.034511394798755646, -0.0970531702041626, 0.1650056391954422, 0.053071219474077225, 0.11271319538354874, 0.13736385107040405, 0.05572979897260666, 0.10124576091766357, 0.14724498987197876, 0.2082420140504837, -0.1656060516834259, 0.1685696840286255, 0.1812363564968109, -0.05822460353374481, 7.247866741719907e-33, 0.03897758573293686, -0.07470735907554626, 0.002242157468572259, 0.028183601796627045, 0.08558942377567291, -0.020745841786265373, -0.0035561006516218185, 0.12011530995368958, 0.010415559634566307, -0.09508804976940155, 0.008346745744347572, 0.015561253763735294, 0.019541945308446884, 0.10204172879457474, -0.05831529200077057, -0.05983410403132439, 0.019289342686533928, -0.024835877120494843, 0.07775449752807617, 0.023531097918748856, 0.018108200281858444, -0.1809590607881546, 0.017100227996706963, -0.04084305092692375, 0.06249208748340607, 0.13750648498535156, 0.062280964106321335, 0.18345126509666443, -0.0344766229391098, 0.052455317229032516, -0.12047633528709412, 0.008592487312853336, -0.004810860846191645, -0.19001992046833038, -0.046247970312833786, -0.08634710311889648, 0.0004460082855075598, -0.09325800836086273, -0.09554655849933624, 0.05533624440431595, 0.009615353308618069, 0.0576222762465477, -0.165684312582016, -0.09864945709705353, 0.13221004605293274, -0.17958864569664001, -0.13381460309028625, 0.011904324404895306, 0.0016699116677045822, 0.10855336487293243, 0.11619921773672104, -0.17308282852172852, 0.03626614436507225, -0.06214490160346031, -0.050842925906181335, 0.017926711589097977, -0.12743143737316132, 0.03940621763467789, 0.09219760447740555, 0.058302123099565506, 0.09593384712934494, 0.07803007960319519, -0.020690875127911568, 0.1146523654460907, -0.1420959085226059, 0.025706453248858452, -0.1627233922481537, -0.06335114687681198, -0.186855286359787, 0.16769294440746307, -0.003804103471338749, -0.058026257902383804, 0.16811051964759827, 0.11839111894369125, 0.07950048893690109, -0.0036005955189466476, 0.015243135392665863, 0.038471758365631104, 0.00931619293987751, -0.15384016931056976, -0.10981623083353043, -0.018921982496976852, -0.2580363154411316, 0.12611299753189087, 0.03953651338815689, -0.021226957440376282, -0.030954523012042046, -0.00884070061147213, -0.19855526089668274, -0.1610962301492691, 0.1775018572807312, 0.08278320729732513, -0.14536023139953613, 0.1853579878807068, -0.06517167389392853, -9.766114330491077e-33, -0.06120270863175392, -0.017658373340964317, -0.13961315155029297, -0.04802989587187767, 0.014325207099318504, 0.13342443108558655, 0.0628172755241394, -0.21616894006729126, 0.2770853042602539, -0.3145943284034729, 0.017371011897921562, 0.02442895993590355, -0.07459252327680588, -0.0860237255692482, -0.030919577926397324, 0.030704472213983536, -0.07209446281194687, -0.13833552598953247, -0.06436945497989655, 0.04074979946017265, 0.11275458335876465, 0.1177903264760971, -0.025260139256715775, 0.03268036991357803, -0.009229033254086971, 0.024147555232048035, 0.142151340842247, 0.03934818133711815, 0.04785136505961418, 0.13248533010482788, 0.05070638656616211, 0.05520598590373993, -0.2193426787853241, -0.03033480793237686, -0.10980723798274994, 0.12489547580480576, 0.061883240938186646, -0.15589305758476257, -0.03696722537279129, 0.0037129814736545086, -0.005702551454305649, 0.14159393310546875, -0.10028065741062164, -0.06522593647241592, -0.01448143646121025, 0.10799814015626907, 0.07595609128475189, -0.061682507395744324, 0.19389356672763824, 0.054933302104473114, 0.08827302604913712, -0.032518208026885986, 0.03747059777379036, 0.1072467565536499, -0.09287315607070923, -0.1249660849571228, -0.027815960347652435, 0.009723133407533169, -0.06358879804611206, 0.018109727650880814, -0.07559791952371597, 0.10994032025337219, 0.02693522535264492, 0.07016656547784805, 0.14973857998847961, 0.1019178032875061, 0.11709535866975784, -0.06561948359012604, 0.12216070294380188, -0.09172488749027252, -0.17636370658874512, -0.13332019746303558, -0.05115750804543495, 0.16547928750514984, 0.09908220171928406, 0.13622716069221497, 0.000703474972397089, -0.06522034853696823, -0.11567696928977966, -0.10755832493305206, -0.10770777612924576, -0.0857258290052414, -0.054408635944128036, 0.03913501650094986, -0.040079206228256226, -0.034789033234119415, -0.11095139384269714, 0.05121607705950737, 0.06567314267158508, 0.13639910519123077, -0.017848283052444458, -0.025414712727069855, -0.1822388768196106, -0.07306267321109772, -0.016864493489265442, -1.0096100311329792e-07, 0.15327319502830505, -0.1737179458141327, -0.09273228049278259, -0.04932166635990143, -0.08847758173942566, 0.0016222973354160786, -0.10873766988515854, 0.03509216010570526, -0.0020184924360364676, 0.02016536146402359, 0.15948358178138733, 0.25269773602485657, -0.05728863179683685, 0.005559036508202553, 0.024156492203474045, 0.030127307400107384, 0.07763974368572235, 0.04629368707537651, -0.12831714749336243, -0.026610512286424637, -0.21632933616638184, 0.02593633532524109, -0.03287392854690552, -0.10879316180944443, -0.01093367487192154, -0.06910128891468048, 0.008152186870574951, 0.044808510690927505, -0.021708399057388306, -0.020261291414499283, 0.020233474671840668, 0.07776929438114166, 0.05317334830760956, -0.01617182418704033, -0.07280609011650085, -0.08780333399772644, 0.07946853339672089, 0.0837693065404892, 0.04833488166332245, 0.146297886967659, -0.041909292340278625, -0.049443770200014114, -0.17129890620708466, -0.09744717925786972, -0.06595268845558167, -0.09604481607675552, -0.10463136434555054, 0.15033015608787537, -0.06612244248390198, -0.0889006108045578, -0.04138506203889847, 0.05866594612598419, -0.018884658813476562, 0.01943112723529339, -0.0645219087600708, 0.16501906514167786, -0.058485470712184906, -0.10729177296161652, 0.1292625367641449, -0.16219866275787354, 0.1785246580839157, -0.04843144863843918, 0.07082948088645935, -0.04032671079039574], "changes": {"1wk": 5.67465694632395, "1mo": -3.0264788942428678}}]